{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "6e80e3df",
   "metadata": {},
   "source": [
    "As a first step I want to prepare the pdbbind data for the runner. Steps:\n",
    "\n",
    "- Check index file annotations and remove flagged complexes if needed\n",
    "    - X-mer as name (I dont want peptides)\n",
    "    - covalent complexes\n",
    "    - incomplete ligands\n",
    "    - redundant entries\n",
    "- Check if the mol2 is parsable and contains hydrogens\n",
    "    - it is not, so I will need to use the sdfs\n",
    "- Apply ligand filters\n",
    "    - Number of heavy atoms\n",
    "    - QED values?\n",
    "    - Rare elements\n",
    "- Clean the pdb files\n",
    "    - Remove all chains without ligand contact\n",
    "    - Remove all hetero atoms without ligand contact and all waters\n",
    "    - Flag structures with water close to the ligand\n",
    "- Check for total size of protein and remove too large ones\n",
    "\n",
    "Repeat on Astex and posebuster files, but without removing entries for now. Only flag them.\n",
    "\n",
    "Hydrogen investigations:\n",
    "- Does Rosetta change hydrogens on ligands?\n",
    "    - I don't think so, but I will stick to placing hydrogens using Roccos reprotonate function. Therefore I will ignore hydrogens depending on the input\n",
    "- Do pdb files contain hydrogens? Does Rosetta alter them?\n",
    "    - Same as above, I don't think so. But since hydrogens are not resolved during experiments, I will allow Rosetta to place them\n",
    "- Is there a difference between pdbbind mol2 and the rcsb pdb ligand file?\n",
    "    - Yes, big time. PDBBind, rscb, sdf, mol2, CCD, all disagree with each other. I will therefore only consider heavy atoms and use a standardized pipeline to automatically place hydrogens. This might be wrong, but it is an end-to-end pipeline and I will assess the perfomance solely based on the ability to calculate heavy atom positions\n",
    "\n",
    "Following the last point above (disagreement between different file sources), I will also only use kekule structures, as this is generally easier to obtain."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "44b434f7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "removed ids: 6801\n",
      "kept ids: 12734\n",
      "unknown flags: 976\n",
      "{'peptide (xmer)': 2455, 'covalent': 662, 'incomplete ligand': 520, 'redundant': 181, 'resolution': 2885, 'NMR': 98}\n"
     ]
    }
   ],
   "source": [
    "removed_ids = []\n",
    "pdb_ids = []\n",
    "\n",
    "# filter based on pdbbind index file\n",
    "\n",
    "remove_flags = ['peptide (xmer)', 'covalent', 'incomplete ligand', 'redundant', 'resolution', 'NMR']\n",
    "remove_counter = {}\n",
    "for f in remove_flags:\n",
    "    remove_counter[f] = 0\n",
    "allowed_flags = ['ligand is', 'kd', 'ic50', 'ki', '+/-', 'ph', 'isomer', 'contain', 'temp', 'kon', 'koff',\n",
    "                 'supplementary information', 'crystal', 'complex', 'mm',\n",
    "                'fragment', 'affinity',\n",
    "                'assay',\n",
    "                'binding',\n",
    "                'bortezomib',\n",
    "                'carfilzomib',\n",
    "                'compound ',\n",
    "                'mutation: yes',\n",
    "                'residues ',\n",
    "                'different ligand structure']\n",
    "unknown_flags = {}\n",
    "\n",
    "with open('pdbbind_2020plus/INDEX_general_PL.2020R1.lst') as file:\n",
    "    for line in file:\n",
    "        if line[0] == '#':\n",
    "            continue\n",
    "        line = line.strip().split('//')\n",
    "        pdb_id = line[0].split()[0]\n",
    "        resolution = line[0].split()[1]\n",
    "        ligand_name = line[1].split('(')[1].split(')')[0]\n",
    "        flags = ''.join(line[1].split(')')[1:]).strip().split(';')\n",
    "        if flags[0] == '' and len(flags) == 1:\n",
    "            flags = []\n",
    "        if ligand_name[-3:] == 'mer':\n",
    "            flags.append('peptide (xmer)')\n",
    "        removed = False\n",
    "        for f in flags:\n",
    "            f = f.strip().lower()\n",
    "            for remove_flag in remove_flags:\n",
    "                if remove_flag in f:\n",
    "                    removed_ids.append((pdb_id, remove_flag))\n",
    "                    remove_counter[remove_flag] += 1\n",
    "                    removed = True\n",
    "                    break\n",
    "        \n",
    "        if not removed:\n",
    "            try:\n",
    "                resolution = float(resolution)\n",
    "                if resolution > 2.5:\n",
    "                    removed_ids.append(pdb_id)\n",
    "                    remove_counter['resolution'] += 1\n",
    "                    removed = True\n",
    "            except:\n",
    "                removed_ids.append(pdb_id)\n",
    "                remove_counter['NMR'] += 1\n",
    "                removed = True\n",
    "\n",
    "        if not removed:\n",
    "            for f in flags:\n",
    "                f = f.strip().lower()\n",
    "                subflags = f.split(', ')\n",
    "                for sf in subflags:\n",
    "                    allowed = False\n",
    "                    for af in allowed_flags:\n",
    "                        if af in sf:\n",
    "                            allowed = True\n",
    "                    if not allowed and sf != '':\n",
    "                        if sf not in unknown_flags:\n",
    "                            unknown_flags[sf] = 0\n",
    "                        unknown_flags[sf] += 1\n",
    "\n",
    "        if not removed:\n",
    "            pdb_ids.append(pdb_id)\n",
    "\n",
    "print('removed ids:', len(removed_ids))\n",
    "print('kept ids:', len(pdb_ids))\n",
    "print('unknown flags:', len(unknown_flags))\n",
    "print(remove_counter)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "17707ad8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('km atp', 8)\n",
      "('with adohcy', 7)\n",
      "('direct itc', 7)\n",
      "('chain bd: 363', 7)\n",
      "('ec 2.7.7.49/ 2.7.7.7/ 3.1.26.4', 6)\n",
      "('onx 0914', 6)\n",
      "('bromoscan bromodomain selectivity data', 6)\n",
      "('determined by \"low c value\" itc', 6)\n",
      "('bio-layer interferometry experiment', 6)\n",
      "('inhibitor 1', 5)\n",
      "('inhibitor 3', 5)\n",
      "('belta-5i', 5)\n",
      "('onx0914', 5)\n",
      "(\"denv 2'o-mtase activity\", 5)\n",
      "('according to structure in rcsb pdb', 5)\n",
      "('pfa-m1', 5)\n",
      "('itc', 4)\n",
      "('3', 4)\n",
      "('protein from bacillus subtilis', 4)\n",
      "('camp and camp-inhibited cgmp 3', 4)\n",
      "('homogeneoustime-resolved  fluorescence', 4)\n",
      "('measured with adohcy', 4)\n",
      "('spa method', 4)\n",
      "('mutation e281a', 4)\n",
      "('e354a', 4)\n",
      "('followed by tautomerization to an enamine.', 4)\n",
      "('ligand: fmvapp', 4)\n",
      "('sch772984', 4)\n",
      "('spr data is available', 4)\n",
      "('lpc substrate', 4)\n",
      "('protein is e119d', 4)\n",
      "('2', 3)\n",
      "('incomplete structure', 3)\n",
      "('data not shown', 3)\n",
      "('n55m', 3)\n",
      "('v59i', 3)\n",
      "('q99v', 3)\n",
      "('p100n', 3)\n",
      "('inhibitor 2', 3)\n",
      "('multiple ligands', 3)\n",
      "('in reference', 3)\n",
      "('cf3 group is different from o-ch3 in pdb', 3)\n",
      "('x-ray(human pde4d', 3)\n",
      "('measured with mn2+', 3)\n",
      "('with mg2+', 3)\n",
      "('pdb error', 3)\n",
      "('prk1 wild-type', 3)\n",
      "('itc data is available', 3)\n",
      "('15n-hsqc experiments', 3)\n",
      "('to k-rasg12d', 3)\n",
      "('pak4 ser residue modified', 3)\n",
      "('with atp present at 21um', 3)\n",
      "('with atp present at 10.7um', 3)\n",
      "('for gram-negative enteric bacterial rnap', 3)\n",
      "('allosteric inhibitor', 3)\n",
      "('itc data available', 3)\n",
      "('2-aminopyridine', 3)\n",
      "('aniline', 3)\n",
      "('lm-12b', 3)\n",
      "('cip-as', 3)\n",
      "('protein is tnms3', 3)\n",
      "('raloxifene', 2)\n",
      "('racemic ligand', 2)\n",
      "('x-ray(tcache', 2)\n",
      "('arylamide inhibits cfms', 2)\n",
      "('mutation(s266a', 2)\n",
      "('v353g', 2)\n",
      "('q452n', 2)\n",
      "('x-ray(plsmt', 2)\n",
      "('include aicar transformylase and imp cyclohydrolase', 2)\n",
      "('trehalose', 2)\n",
      "('s345c', 2)\n",
      "('mutations:d37h', 2)\n",
      "('k40h', 2)\n",
      "('k125h', 2)\n",
      "('k132h', 2)\n",
      "('k223h', 2)\n",
      "('k264h', 2)\n",
      "('k57a', 2)\n",
      "('r28k mutant', 2)\n",
      "('p212121', 2)\n",
      "('pcdk2', 2)\n",
      "('see supplement data', 2)\n",
      "('genistein', 2)\n",
      "('x-ray structure(gpb', 2)\n",
      "('n-acetyl-d-galactosamine', 2)\n",
      "('n=3', 2)\n",
      "('measured at 20c', 2)\n",
      "('inhibitor 9', 2)\n",
      "('glur2 ampa receptor with ubp277', 2)\n",
      "('in ref15', 2)\n",
      "('with gsk3-beta peptide', 2)\n",
      "('753-922', 2)\n",
      "('mutation: c584s', 2)\n",
      "('x-ray(rock1', 2)\n",
      "('with gsk 3 beta peptide', 2)\n",
      "('with incomplete 14-mer coactivator', 2)\n",
      "('beta-cyclodextrin', 2)\n",
      "('inhibit the enzyme competitively with respect to sarcosine', 2)\n",
      "('structure:with adohcy', 2)\n",
      "('5-dichlorocatechol', 2)\n",
      "('gdp', 2)\n",
      "('structure for glua2-s1s2', 2)\n",
      "('structure(catalytic domain', 2)\n",
      "('p21-a', 2)\n",
      "('imi', 2)\n",
      "('303-393', 2)\n",
      "('x-ray:adam-ts1', 2)\n",
      "('mutation:i37v', 2)\n",
      "('i98s', 2)\n",
      "('mutation v123a', 2)\n",
      "('l173m', 2)\n",
      "('q181k', 2)\n",
      "('x-ray(pkab3 mutation', 2)\n",
      "('che', 2)\n",
      "('deq', 2)\n",
      "('space group p21', 2)\n",
      "('x-ray(mouse', 2)\n",
      "('4', 2)\n",
      "('x-ray((s-configuration at the c4 of the bicyclic ring', 2)\n",
      "('x-ray (wt dhqd', 2)\n",
      "('x-ray(z', 2)\n",
      "('ligand=dpgp', 2)\n",
      "('q85m', 2)\n",
      "('q131e mutation', 2)\n",
      "('hrbp4 spa', 2)\n",
      "('astex', 2)\n",
      "('tr-fret', 2)\n",
      "('-dtt', 2)\n",
      "('c-di-gmp binds to wt bcsa-b', 2)\n",
      "(\"author's problem\", 2)\n",
      "('biolayer interferometry', 2)\n",
      "('ypynta binds to ni(l-his2', 2)\n",
      "('competitive inhibition data versus varied aldehyde', 2)\n",
      "('rscbby mutant d10n', 2)\n",
      "('brij 35 0.05%', 2)\n",
      "('with atp present at 125um', 2)\n",
      "('10 mg/ml bsa', 2)\n",
      "('5% methanol', 2)\n",
      "('gbcd', 2)\n",
      "('functional kb value', 2)\n",
      "('e.g. dovitinib', 2)\n",
      "('n67q', 2)\n",
      "('i91l', 2)\n",
      "('f130v', 2)\n",
      "('v134l', 2)\n",
      "('also named as sia in rcsb', 2)\n",
      "('potent allosteric inhibitor bislysine', 2)\n",
      "('[multiple sites: site 1:13nm', 2)\n",
      "('spr data', 2)\n",
      "('x-ray(cats c25s', 2)\n",
      "('against ethr-dna106', 2)\n",
      "('octopine', 2)\n",
      "('usp7/1', 2)\n",
      "('pugnac', 2)\n",
      "('3-mdpa', 2)\n",
      "('ligt/atp', 2)\n",
      "('x-ray diffraction (100k', 2)\n",
      "('x-ray diffraction (295k', 2)\n",
      "('joint x-ray/neutron diffraction (295k', 2)\n",
      "('az51', 2)\n",
      "('hmbpp', 2)\n",
      "('sb4-208', 2)\n",
      "('sb4-206', 2)\n",
      "('at 350nm', 2)\n",
      "('four', 1)\n",
      "('or seven tfp molecules bound to cam', 1)\n",
      "('[different protein: epsilon-thrombin in pdb structure', 1)\n",
      "('5p2', 1)\n",
      "('z-pro-prolinal', 1)\n",
      "('structure is gst mutant', 1)\n",
      "('not human', 1)\n",
      "('2-dcp', 1)\n",
      "('tris inhibit dgmii', 1)\n",
      "('e. coli quinol-fumarate reductase with hqno', 1)\n",
      "('protein is ptpn1', 1)\n",
      "('racemic ligand byp/bwp', 1)\n",
      "('nqno1 binds to bc1', 1)\n",
      "('ampa', 1)\n",
      "('data from ref.25', 1)\n",
      "('(4-oht', 1)\n",
      "('a hydroxamate peptidic compound', 1)\n",
      "('azoxystrobin', 1)\n",
      "('dana', 1)\n",
      "('olomoucine', 1)\n",
      "('myxothiazol to bovine and yeast bc1', 1)\n",
      "('moas to bovine bc1', 1)\n",
      "('to yeast bc1', 1)\n",
      "('1996', 1)\n",
      "('vol.39', 1)\n",
      "('pp.892-903', 1)\n",
      "('dhbnh inhibit rt-rnh', 1)\n",
      "('dihydrotestosterone', 1)\n",
      "('quinolone inhibits cfms', 1)\n",
      "('prop compound', 1)\n",
      "('mutations(s452a', 1)\n",
      "('t493a', 1)\n",
      "('k455a', 1)\n",
      "('c500s', 1)\n",
      "('ec50=5.3nm', 1)\n",
      "('x-ray(source=a.aeolicus', 1)\n",
      "('x-ray(source=human', 1)\n",
      "('ligand:cis', 1)\n",
      "('ligand:trans', 1)\n",
      "('for holoflavodoxin and benzamidine', 1)\n",
      "('20-70', 1)\n",
      "('two hydroxyl groups', 1)\n",
      "('different from reference.', 1)\n",
      "('mw>1000', 1)\n",
      "('2p-adp-ribose', 1)\n",
      "('wt pure with no2-air', 1)\n",
      "('peramivir', 1)\n",
      "('tit1330', 1)\n",
      "('maltose', 1)\n",
      "('cellobiose', 1)\n",
      "('for native 1-feh iia', 1)\n",
      "('x-ray(s-ns1209', 1)\n",
      "('ligand structure is different in reference', 1)\n",
      "('in pdb database', 1)\n",
      "('not aromatic cycle', 1)\n",
      "('time-dependent inhibition', 1)\n",
      "('pka-pkb-1', 1)\n",
      "('measured by fret', 1)\n",
      "('ligand difference: cn -> ch2nh2', 1)\n",
      "('mw=287.31', 1)\n",
      "('ec50(cea=690nm', 1)\n",
      "('superseded by 2uue', 1)\n",
      "('z:e>98:1', 1)\n",
      "('4-chlorocinnamic hydroxamate', 1)\n",
      "('0% hs', 1)\n",
      "('50% hs', 1)\n",
      "('ng-dimethylarginine dimethylaminohydrolase 1 with l-257', 1)\n",
      "('k368h', 1)\n",
      "('monkey dimeric dd', 1)\n",
      "('minodronate', 1)\n",
      "('t0901317', 1)\n",
      "('polymer 2: nuclear receptor coactivator 1', 1)\n",
      "('ec. no. 2.3.1.48', 1)\n",
      "('l-arginine hydroxamate', 1)\n",
      "('bound ligand to be ins(1', 1)\n",
      "('5', 1)\n",
      "('6p5', 1)\n",
      "('not ip6', 1)\n",
      "('form-1', 1)\n",
      "('form-2', 1)\n",
      "('jnk1 inhibitor 2b', 1)\n",
      "('t183e', 1)\n",
      "('y183e', 1)\n",
      "('ka=2.22x10+9m-1', 1)\n",
      "('wide type', 1)\n",
      "('e401k mutant', 1)\n",
      "('ligand in structure is retinoic acid', 1)\n",
      "('ligand in structure is retinal', 1)\n",
      "('ntpase p4 protein s252a mutant', 1)\n",
      "('h45q mutant', 1)\n",
      "('from apo-form soaked for 30 days', 1)\n",
      "('h45n mutant', 1)\n",
      "('measured in the presence of mg2+', 1)\n",
      "('e368h', 1)\n",
      "('n199a mutant', 1)\n",
      "('mutation:e138a', 1)\n",
      "('c58a', 1)\n",
      "('measured by itc', 1)\n",
      "('bz(1', 1)\n",
      "('mutations(i37v', 1)\n",
      "('m56i', 1)\n",
      "('i57g', 1)\n",
      "('g62f', 1)\n",
      "('k63i', 1)\n",
      "('l97t', 1)\n",
      "('i98p', 1)\n",
      "('l101i', 1)\n",
      "('ec50=0.70um', 1)\n",
      "('ligand difference: c=o -> c-oh', 1)\n",
      "('open ring product', 1)\n",
      "('ec50=1.1um', 1)\n",
      "('crotonase superfamily', 1)\n",
      "('ump', 1)\n",
      "('deaminohydroxy blasticidin s', 1)\n",
      "('isoform hca i', 1)\n",
      "('co2+ hmetap2b', 1)\n",
      "('mn2+ hmetap2b', 1)\n",
      "('mic.app=92um', 1)\n",
      "('mutations(q506k,l532i,l562i,c566a,v581a,c594a', 1)\n",
      "('wild type protein', 1)\n",
      "('p101s mutant', 1)\n",
      "('ec50=0.18um', 1)\n",
      "('pka-pkb-2', 1)\n",
      "('p101l mutant', 1)\n",
      "('acc', 1)\n",
      "('space group:  p 21 21 21', 1)\n",
      "('sinefungin', 1)\n",
      "('benzylsulfonamide-d-ile-gln-p-aminobenzamidine', 1)\n",
      "('inhibitor 7', 1)\n",
      "('rcsb is jnf', 1)\n",
      "('like analogue 8', 1)\n",
      "('(s-8b', 1)\n",
      "('ed50=8.9um', 1)\n",
      "('x-ray(pfspds', 1)\n",
      "('inhibitor 2f', 1)\n",
      "('rcsb is jno', 1)\n",
      "('like analogue 2', 1)\n",
      "('c35 is ligand ncp09', 1)\n",
      "('rat microsomal hmgcoa reductase inhibition.', 1)\n",
      "('human dcps', 1)\n",
      "('data not sure', 1)\n",
      "('inhibitor 2e', 1)\n",
      "('indazolylpyrimidine 5a', 1)\n",
      "('inhibitor k510', 1)\n",
      "('close to a 14-mer peptide', 1)\n",
      "('mutation: prescission protease site 18', 1)\n",
      "('19', 1)\n",
      "('different from gw7', 1)\n",
      "('a triple bond to a single bond', 1)\n",
      "('can not be reliably determined', 1)\n",
      "('but expected to mirror the potency of taf089', 1)\n",
      "('x \\\\ray (mouse cn2', 1)\n",
      "('lead inhibitor 1', 1)\n",
      "('inhibitor 2q', 1)\n",
      "('x-ray structure(jnk3/46c', 1)\n",
      "('mouse ferrochelatase', 1)\n",
      "('protein mutant c1g', 1)\n",
      "('correspond to code ne6', 1)\n",
      "('one-legged heme-reconstituted p450cam', 1)\n",
      "('pdx', 1)\n",
      "('ka=517', 1)\n",
      "('000m-1', 1)\n",
      "('only act holo-acp', 1)\n",
      "('tmpank-iii dimer', 1)\n",
      "('r307e was even more severely reduced', 1)\n",
      "('nicotinate adenine dinucleotide (naad', 1)\n",
      "('not d365a mutant', 1)\n",
      "('(+-ehna', 1)\n",
      "('inhibitor 24', 1)\n",
      "('human', 1)\n",
      "('recombinant isozymes.', 1)\n",
      "('cheng-prusoff', 1)\n",
      "('420', 1)\n",
      "('340nm', 1)\n",
      "('ligand in reference is referred to as formycin a (fma', 1)\n",
      "('a620223', 1)\n",
      "('products 2', 1)\n",
      "('tgf beta=0.095um', 1)\n",
      "('tgf beta=0.09um', 1)\n",
      "('5 benzodiazepine inhibitor (r-11d', 1)\n",
      "('structure of 8a bound to cruzain', 1)\n",
      "('bdm31381', 1)\n",
      "('in reference table 2', 1)\n",
      "('n should be 1', 1)\n",
      "('not 2', 1)\n",
      "('bcx-34', 1)\n",
      "('urea transporter bound to 1', 1)\n",
      "('3-dimethylurea', 1)\n",
      "('jak1-cp-690', 1)\n",
      "('inhibitor 17', 1)\n",
      "('three quite different data in references', 1)\n",
      "('1.26x10-8m', 1)\n",
      "('see support info', 1)\n",
      "('combine 3 letter code ligand 2ht and 3ht', 1)\n",
      "('rjf 00670 with bifunctional quadruple mutant ts-dhfr', 1)\n",
      "('jak2-cp-690', 1)\n",
      "('wrong n cycle is aromatic in pdb', 1)\n",
      "('the author miss a carbon atom in reference', 1)\n",
      "('cathepsin l with az13010160', 1)\n",
      "('2nm', 1)\n",
      "('not 2.76nm', 1)\n",
      "('aminoheterocycles as a novel beta-secretase inhibitor', 1)\n",
      "('tak-442', 1)\n",
      "('inhibition rate 51% at 3.6um', 1)\n",
      "('incubated with the enzyme and 10um fpp', 1)\n",
      "('pmp is a cofactor', 1)\n",
      "('x-ray structure(soak', 1)\n",
      "('include special element b', 1)\n",
      "('gsamwt-mcpp', 1)\n",
      "('structure 5 bound to c delta 21 ns5b polymerase', 1)\n",
      "('bx-2819 binds to hsp90', 1)\n",
      "('structure lack a ch2', 1)\n",
      "('monoclinic form', 1)\n",
      "('orthorhombic form', 1)\n",
      "('structure 18 bound to cd21 ns5b polymerase', 1)\n",
      "('structure 16 bound to c delta 21 ns5b polymerase', 1)\n",
      "('glucocorticoid receptor with bound d-prolinamide 11', 1)\n",
      "('human adometdc and dmama', 1)\n",
      "('inhibitor efp with cdk-2', 1)\n",
      "('9nm x 7=63nm', 1)\n",
      "('inhibitor efq with cdk-2', 1)\n",
      "('95nm x 0.7=66.5nm', 1)\n",
      "('pde9a inhibitor 7 bound in pde9a', 1)\n",
      "('bk strain', 1)\n",
      "('delta 21 construct', 1)\n",
      "('soluble epoxide hydrolase and inhibitors 24', 1)\n",
      "('rats=9nm', 1)\n",
      "('papaverine', 1)\n",
      "('5-cyano-ump', 1)\n",
      "('soluble epoxide hydrolase and inhibitors 1', 1)\n",
      "('rats=4.8nm', 1)\n",
      "('heme bound with hasa-hasr', 1)\n",
      "('2-mercapto(3hquinazolinone', 1)\n",
      "('x-ray(na+,k+ atpase', 1)\n",
      "('ka=9.5x10+4m-1', 1)\n",
      "('p+l-p.l-p.l.l4', 1)\n",
      "('two equilirium', 1)\n",
      "('not fmn', 1)\n",
      "('s100a7 with 1,8 ans', 1)\n",
      "('s100a7 with 2,6 ans', 1)\n",
      "('eqkm mutant', 1)\n",
      "('aracmp', 1)\n",
      "('pep and peq are the same ligands', 1)\n",
      "('hhdod for rf', 1)\n",
      "('two fold weak than r234w mutant', 1)\n",
      "('ka=4.5x10+4m-1', 1)\n",
      "('acetyl-coa acetyltransferase h348n mutant with coenzyme a', 1)\n",
      "('visfatin with is001', 1)\n",
      "('nor-noha (nx-hydroxy-nor-larginine', 1)\n",
      "('acetyl-coa acetyltransferase n316a mutant with coenzyme a', 1)\n",
      "('ka=1.9x10+4m-1', 1)\n",
      "('(+-aba-bound pyl1', 1)\n",
      "('acetyl-coa acetyltransferase h348a mutant with coenzyme a', 1)\n",
      "('ka=1.2x10^4m-1', 1)\n",
      "('x-ray structure(w154a-peng', 1)\n",
      "('cdv', 1)\n",
      "('inhibitors 14', 1)\n",
      "('special b atom in ligand', 1)\n",
      "('adducts of sulfamates 2 with hca ii', 1)\n",
      "('lbd of rabbit and human proteins are identical', 1)\n",
      "('5-fluoro-6-iodo-ump', 1)\n",
      "('but pdb still is 5fu', 1)\n",
      "('pparg with int131', 1)\n",
      "('casuarine 6-o-a-glucopyranoside', 1)\n",
      "('ampm inhibitor', 1)\n",
      "('adducts of sulfamates 3 with hca ii', 1)\n",
      "('ligand b', 1)\n",
      "('mpd', 1)\n",
      "('not yellow fever', 1)\n",
      "('competitive inhibitor', 1)\n",
      "('data from ref. 25', 1)\n",
      "('adducts of sulfamates 1 with hca ii', 1)\n",
      "('adducts of sulfamates 4 with hca ii', 1)\n",
      "('ac activity inhibition by ppi-ca2+', 1)\n",
      "('in ref.15', 1)\n",
      "('ligand a', 1)\n",
      "('yeast 20s proteasome with syringolin b', 1)\n",
      "('catalytic domain of tace with inhibitor 8', 1)\n",
      "('lack a nh2 group', 1)\n",
      "('not 1.3um', 1)\n",
      "(' ligand end is -ch3 or -ch2ch3', 1)\n",
      "('5.6(human plasma', 1)\n",
      "('7.5(human plasma', 1)\n",
      "('ec50=9.1um', 1)\n",
      "('not 5d', 1)\n",
      "('x-ray(wnv mtase', 1)\n",
      "(\"19um(inhibition 2'-o-methylation\", 1)\n",
      "('space group: p 21', 1)\n",
      "('space group: p 21 21 21', 1)\n",
      "('(r-dw12', 1)\n",
      "('scf-i2', 1)\n",
      "('9nm(biochemical analyses', 1)\n",
      "('ligand fk506', 1)\n",
      "('pyrrolidine 1', 1)\n",
      "('alkylpyrrolidine ligand', 1)\n",
      "('inhibitor 1_02_1', 1)\n",
      "('nnrti tmc-125 etravirine', 1)\n",
      "('10%fbs', 1)\n",
      "('40%hus', 1)\n",
      "('leukotriene a4 hydrolase with inhibitor 2', 1)\n",
      "('bioorg med chem lett. 12: 3383-6 (2002', 1)\n",
      "('pfv s217h mutant intasome bound to magnesium and the insti mk2048', 1)\n",
      "('inhibitor sar37', 1)\n",
      "('pfv n224h mutant intasome bound to magnesium and the insti mk2048', 1)\n",
      "('with cyclint1', 1)\n",
      "('x-ray(cdk9 2-330', 1)\n",
      "('sar57', 1)\n",
      "('an aminoindazole type inhibitor', 1)\n",
      "('for jmjd2a', 1)\n",
      "('66nm(pp-p38', 1)\n",
      "('8nm(pp-p38', 1)\n",
      "('biochemical analyses', 1)\n",
      "('supersedes code 3kwh', 1)\n",
      "('a synthetic divalent carbohydrate ligand', 1)\n",
      "('x-ray(catalytic domain', 1)\n",
      "('inhibitor viii', 1)\n",
      "('dasatinib', 1)\n",
      "('mutation: l55f', 1)\n",
      "('for detergent additive ddq', 1)\n",
      "('for another buffer ligand mes', 1)\n",
      "('with cyclina', 1)\n",
      "('ligand web-3', 1)\n",
      "('x-ray(pin1r14a', 1)\n",
      "('platencin a1', 1)\n",
      "('bace bound to sch589432', 1)\n",
      "('wrr-483', 1)\n",
      "('x-ray', 1)\n",
      "('catechol cfe(iii', 1)\n",
      "('c-udp', 1)\n",
      "('1-wk', 1)\n",
      "('glutathione disulfide(gssg', 1)\n",
      "('x-ray:with adohcy', 1)\n",
      "('inhibitor ro5191614', 1)\n",
      "('1b_j4 polymerase', 1)\n",
      "('pdb is 1a', 1)\n",
      "('but reference indicates 1b', 1)\n",
      "('dfbp-o for the regulatory domain of ctnc in presence of ctni', 1)\n",
      "('noha (nx-hydroxy-l-arginine', 1)\n",
      "('1-mth', 1)\n",
      "('structure(mgatp', 1)\n",
      "('steady-state and reductive half-reactions', 1)\n",
      "('not gimap2(1-234', 1)\n",
      "('x-ray(with product ade', 1)\n",
      "('with jaz1 degron', 1)\n",
      "('measured at low 2-og concentrations', 1)\n",
      "('glycolipid bbgl-2c', 1)\n",
      "('with ca2+', 1)\n",
      "('not gimap2 (21-260', 1)\n",
      "('with imatinib', 1)\n",
      "('structure(mgadp', 1)\n",
      "('1a_18 polymerase', 1)\n",
      "('pdb is 1b', 1)\n",
      "('but reference indicates 1a', 1)\n",
      "('close conformation', 1)\n",
      "('open conformation', 1)\n",
      "('ligand structure is not consist with the one in reference', 1)\n",
      "('structure(hsp90beta', 1)\n",
      "('rcsb ligand structure no f atom', 1)\n",
      "('ligand name m44 is ddp', 1)\n",
      "('ligand gemsa', 1)\n",
      "('ligand structure is not consist with reference', 1)\n",
      "('mutation: m543a', 1)\n",
      "('with ipp', 1)\n",
      "('with co2+', 1)\n",
      "('the active metabolite of 5-fu', 1)\n",
      "('cefoperazone batsi', 1)\n",
      "('ceftazidime batsi', 1)\n",
      "('competitive inhibitors of sco3058', 1)\n",
      "('2-aminoimidazole is a weak noncompetitive inhibitor', 1)\n",
      "('mutations(q506k', 1)\n",
      "('l532i', 1)\n",
      "('l562i', 1)\n",
      "('c566a', 1)\n",
      "('c594a', 1)\n",
      "('gtp', 1)\n",
      "('fellutamide b', 1)\n",
      "('with fe2+', 1)\n",
      "('structure(d101l hdac8', 1)\n",
      "('competitive inhibitor dapir', 1)\n",
      "('x-ray:in i222 spacegroup', 1)\n",
      "('space group:  p 21', 1)\n",
      "('use full length protein', 1)\n",
      "('with cyclint', 1)\n",
      "('12.3(plasma', 1)\n",
      "('mutation: n-terminal his tag', 1)\n",
      "('thapsigargin', 1)\n",
      "('r-18a', 1)\n",
      "('0.30nm(36pm renin and 1.1nm (plasma', 1)\n",
      "('0.42nm(36pm renin and 0.48nm (plasma', 1)\n",
      "('mutation: y987f', 1)\n",
      "('structure is a little diffrent from pdb', 1)\n",
      "('6s-37c', 1)\n",
      "('resudes 2-761', 1)\n",
      "('ligand structure in reference is a little different from pdb', 1)\n",
      "('x-ray:aalpxc', 1)\n",
      "('with jip1 peptide', 1)\n",
      "('mutation: m91i', 1)\n",
      "('y95c', 1)\n",
      "('mutation: s2a', 1)\n",
      "('mutation: e303a', 1)\n",
      "('k304a', 1)\n",
      "('6r-28a', 1)\n",
      "('mutation: k124a', 1)\n",
      "('t287a', 1)\n",
      "('t288a', 1)\n",
      "('pro', 1)\n",
      "('ligand code is 3w4 or 3w5', 1)\n",
      "('mutation: t288d', 1)\n",
      "('ec50=4nm', 1)\n",
      "('mutation: v924r', 1)\n",
      "('x-ray:bms3:ftase:fpp', 1)\n",
      "('x-ray: bms3:rabggtase:ggpp', 1)\n",
      "('324-675', 1)\n",
      "('mutation: s482a', 1)\n",
      "('s487a', 1)\n",
      "('s489a', 1)\n",
      "('not accuraacy', 1)\n",
      "('~0.1m (substrate monosaccharide', 1)\n",
      "('2-mer ligand', 1)\n",
      "('with mgamp-pnp', 1)\n",
      "('ida', 1)\n",
      "('mutation: k67s', 1)\n",
      "('c72a', 1)\n",
      "('e90q', 1)\n",
      "('c141s', 1)\n",
      "('mutation: g680a', 1)\n",
      "('dimer ligand', 1)\n",
      "('protein mutant d776k', 1)\n",
      "('667-806', 1)\n",
      "('mutation: t183e', 1)\n",
      "('y185e', 1)\n",
      "('the unactuvated protein', 1)\n",
      "('([lsl150:(lactosebeta', 1)\n",
      "('either lat or lbt', 1)\n",
      "('mutation: r14a', 1)\n",
      "('calorimetric titration', 1)\n",
      "('the enzyme can bind its first substrate', 1)\n",
      "('dhap', 1)\n",
      "('san', 1)\n",
      "('mutation: f42m', 1)\n",
      "('i149m', 1)\n",
      "('l152m', 1)\n",
      "('deletion h91', 1)\n",
      "('deletion p92', 1)\n",
      "('also in crystral', 1)\n",
      "('mg2+', 1)\n",
      "('na+', 1)\n",
      "('mutation: r164h', 1)\n",
      "('multi component of protein', 1)\n",
      "('mutation: r164s', 1)\n",
      "('ligand not complete in x-ray(hydrolysis product', 1)\n",
      "('human sult1a1 variant b9+pap+pnp', 1)\n",
      "('t=37c', 1)\n",
      "('human sult1a1 variant b9+pap+3cyc', 1)\n",
      "('x-ray(s-dpgp', 1)\n",
      "('mutation r118k', 1)\n",
      "('x-ray: atpdf(r118k', 1)\n",
      "('soak', 1)\n",
      "('x-ray(r-52', 1)\n",
      "('iwr2', 1)\n",
      "('6s-15a', 1)\n",
      "('ampa. maybe wrong data', 1)\n",
      "(\"there is an error in pdb's ligand structrue\", 1)\n",
      "('inhibitor 4', 1)\n",
      "('tolcapone. inhibition of rat brain comt', 1)\n",
      "('x-ray(b-raf', 1)\n",
      "('full-length rnase h', 1)\n",
      "(\"3'\", 1)\n",
      "(\"5'\", 1)\n",
      "('6p5 is not a ship2 substrate but inhibits ins(1', 1)\n",
      "('5p4 hydrolysis', 1)\n",
      "('x-ray((s-16', 1)\n",
      "('x-ray(saccharomyces cerevisiae s288c', 1)\n",
      "('free unbound=10%', 1)\n",
      "('2s', 1)\n",
      "('3r and 2r', 1)\n",
      "('3s', 1)\n",
      "('x-ray(homo sapiens', 1)\n",
      "('not 56um', 1)\n",
      "('add a cl atom', 1)\n",
      "('x-ray(b-raf(wt', 1)\n",
      "('x-ray(human pkm2 with l-serine and fbp bound', 1)\n",
      "('x-ray(udp-mn-tcda', 1)\n",
      "('nmr structure', 1)\n",
      "('x-ray(e. coli liga', 1)\n",
      "('lipid', 1)\n",
      "('not good drugs', 1)\n",
      "('with adp', 1)\n",
      "('na-cnotaining', 1)\n",
      "('but rs chiral bond not identical', 1)\n",
      "('ref 13', 1)\n",
      "('plate form', 1)\n",
      "('in space group p21212', 1)\n",
      "('rod form a', 1)\n",
      "('rod form b', 1)\n",
      "('x-ray(hs odcases', 1)\n",
      "('influenza a virus (a/netherlands/2631_1202/2010(h1n1', 1)\n",
      "('data from ref 11', 1)\n",
      "('rva(z/vae(e', 1)\n",
      "('ligand structure is diffrent: -nh2 and =nh', 1)\n",
      "('ligna is  glcbru', 1)\n",
      "('x-ray(protein: mdd', 1)\n",
      "('x-ray(protein: s192a mdd', 1)\n",
      "('x-ray(hcv ns5b', 1)\n",
      "('x-ray(hdac4 l728a', 1)\n",
      "('x-ray((3s,5r-9', 1)\n",
      "('adtk1', 1)\n",
      "('the ring is open', 1)\n",
      "('x-ray((3s,5r-5', 1)\n",
      "('33% inhibition', 1)\n",
      "('adtk4', 1)\n",
      "('adtk3', 1)\n",
      "('ldn-213844', 1)\n",
      "('ec50=6nm', 1)\n",
      "('inhibitor uw1294', 1)\n",
      "('ide-cf-(1', 1)\n",
      "('hits 1', 1)\n",
      "('32% inhibition', 1)\n",
      "('31% inhibition', 1)\n",
      "('x-ray (b-raf', 1)\n",
      "('x-ray( jnk1-beta', 1)\n",
      "('bdm44619', 1)\n",
      "('convalent bond', 1)\n",
      "('with mg and adp', 1)\n",
      "('1st site', 1)\n",
      "('1xs in site-2', 1)\n",
      "('1dz in site-1', 1)\n",
      "('atp 10um', 1)\n",
      "('atp 30um', 1)\n",
      "('2.4*10^(-9 m(spr', 1)\n",
      "('respectively', 1)\n",
      "('ligand in pdb is rvx-208', 1)\n",
      "('the ligand structure in pdb is wrong.', 1)\n",
      "('5.3*10^(-9 m(spr', 1)\n",
      "('second', 1)\n",
      "('15c', 1)\n",
      "('25c', 1)\n",
      "('0.05nm(+atp', 1)\n",
      "('bound with haa', 1)\n",
      "('k89d mutation', 1)\n",
      "('measure the urea colorimetrically', 1)\n",
      "('95% confidence interval 180-246nm', 1)\n",
      "('(s-carprofen', 1)\n",
      "('wg578', 1)\n",
      "('brd-a33442372', 1)\n",
      "('but two n atoms are different', 1)\n",
      "('brd-a08522488', 1)\n",
      "('wg766', 1)\n",
      "('target is brd2(bd2', 1)\n",
      "('gsk180736a', 1)\n",
      "('was pdb entry 4o73(superseded', 1)\n",
      "('mkc9989 inhibitor', 1)\n",
      "('nsc13778', 1)\n",
      "('ml302 undergoes hydrolysis to give ml302m', 1)\n",
      "('brd2 n-terminal bromodomain', 1)\n",
      "('on page 10506', 1)\n",
      "('fig2', 1)\n",
      "('gsk2163632a', 1)\n",
      "('ligand 2', 1)\n",
      "('in text of pp. 3112', 1)\n",
      "('named 1q1', 1)\n",
      "('target is brd4(bd1', 1)\n",
      "('wg188', 1)\n",
      "('oicr573 inhibitor', 1)\n",
      "('nampt wt', 1)\n",
      "('human whole blood potency', 1)\n",
      "('c-src', 1)\n",
      "('consist of 1p4 and three 18d', 1)\n",
      "('fpp-tipifarnib', 1)\n",
      "('fe-pc', 1)\n",
      "('include metal atom', 1)\n",
      "('k-26. data is for arabbit lung sace', 1)\n",
      "('fpp-ed5', 1)\n",
      "('nampt mutant', 1)\n",
      "('wg176', 1)\n",
      "('33.5 or 34.8um for gpb from refs', 1)\n",
      "('intracellular inhibition', 1)\n",
      "('quercetagetin', 1)\n",
      "('strain j4 (genotype 1b', 1)\n",
      "('consist of 1p0 and three 18d', 1)\n",
      "('oicr464 inhibitor', 1)\n",
      "('citrate anion', 1)\n",
      "('structure in pdb is an open ring', 1)\n",
      "('for y-belta 5 activity', 1)\n",
      "('ruthenium-based inhibitor', 1)\n",
      "('ro5545353', 1)\n",
      "('wild type tafia for biological experiments', 1)\n",
      "('in f815k mutant', 1)\n",
      "('vx787', 1)\n",
      "('substrate c-di-gmp and ca++', 1)\n",
      "('tdf', 1)\n",
      "('pf74', 1)\n",
      "('smarg-abhpe', 1)\n",
      "('smarg-noah', 1)\n",
      "('smarg-nor noah', 1)\n",
      "('bp-2', 1)\n",
      "('smarg-abhdp', 1)\n",
      "('hsting(s162a/g230i/q266i', 1)\n",
      "('bi-2', 1)\n",
      "('4-op', 1)\n",
      "('smarg-abh', 1)\n",
      "('protein is wild type', 1)\n",
      "('data from goldstein et al. 2007', 1)\n",
      "('hsting(s162a/q266i', 1)\n",
      "('pf-04691502', 1)\n",
      "('bi-d', 1)\n",
      "('1,15 or 1.15 x 10-4m', 1)\n",
      "('tak-875', 1)\n",
      "('gsk2801', 1)\n",
      "('tgt mutant asp102asn', 1)\n",
      "('1,46 or 1.46 x 10-4m', 1)\n",
      "('catechol', 1)\n",
      "('tgt mutant asp156asn', 1)\n",
      "('hp-26', 1)\n",
      "('bbp', 1)\n",
      "('6 sln-ln', 1)\n",
      "('a c=c bond is different', 1)\n",
      "('m7gtp-eif4e', 1)\n",
      "('2-pvhl-elo b-eloc', 1)\n",
      "('3 sln-ln', 1)\n",
      "('beta mefuc', 1)\n",
      "('hsting(group2', 1)\n",
      "('the active form of pza', 1)\n",
      "('ps.man9(5', 1)\n",
      "('a synthetic derivative of high-mannose chain', 1)\n",
      "('4-methylcatechol', 1)\n",
      "('using microcalorimetry', 1)\n",
      "('iso-adpr', 1)\n",
      "('adohcy with pcho', 1)\n",
      "('adohcy with pea', 1)\n",
      "('4-tert-butylbenzene-1,2-diol', 1)\n",
      "('cl01131', 1)\n",
      "('itc data', 1)\n",
      "('consist of 1p4 and three sia', 1)\n",
      "('consist of 1p0 and three sia', 1)\n",
      "('modification of alkbh7 leu-110', 1)\n",
      "('consist of sia-mag-gal-fuc', 1)\n",
      "('active site inhibitor s-argatroban', 1)\n",
      "('space group c2', 1)\n",
      "('itc ka=1.09x10e5m-1', 1)\n",
      "('cl03093', 1)\n",
      "('alkbh5 wild-type', 1)\n",
      "('with pr2', 1)\n",
      "('with pr1', 1)\n",
      "('apo-ls-qc-pbd150', 1)\n",
      "('without zn2+', 1)\n",
      "('zn-ls-qc-pbd150', 1)\n",
      "('with zn2+', 1)\n",
      "('l-glu being present in one subunit', 1)\n",
      "('and neither l-asp nor l-glu being present in the other subunit', 1)\n",
      "('2,5-adp', 1)\n",
      "('r-s mixture', 1)\n",
      "('ligand name could be nz2 or nz3', 1)\n",
      "('(6r-5fthf', 1)\n",
      "('miss a ring bond in pdb website', 1)\n",
      "('tartronate was a competitive inhibitor of mr', 1)\n",
      "('competitive reversible inhibitor of bioa with respect to sam. but structure is different from that in pdb', 1)\n",
      "('data from ref (baqi et al.', 1)\n",
      "('2009', 1)\n",
      "('saquinavir(sqv', 1)\n",
      "('znzn(nmdape', 1)\n",
      "('resveratrol(rsv', 1)\n",
      "('incorrect structure', 1)\n",
      "('different from that in pdb', 1)\n",
      "('p2y12r d294 mutant+ bril', 1)\n",
      "('r,s', 1)\n",
      "('k-26. data is for n-domain', 1)\n",
      "('but structure is different from that in pdb', 1)\n",
      "('cho cells', 1)\n",
      "('0.0015um at 40% inhibition', 1)\n",
      "('0.0015um at 54% inhibition', 1)\n",
      "('plx7904', 1)\n",
      "('0.005um at 59% inhibition', 1)\n",
      "('gdc0834', 1)\n",
      "('compoud 14', 1)\n",
      "('bdm44768', 1)\n",
      "('raf265', 1)\n",
      "('carfizomib', 1)\n",
      "('same structure as l-742001', 1)\n",
      "('ampc20', 1)\n",
      "('mk-31', 1)\n",
      "('desisobutyrylciclesonide', 1)\n",
      "('wc01088', 1)\n",
      "('morin', 1)\n",
      "('mrl-367', 1)\n",
      "('jlj555', 1)\n",
      "('kaempferol', 1)\n",
      "('compoud 16a', 1)\n",
      "('0.02% (w/v tween 20', 1)\n",
      "('1% triton x-100 ] inhibitor ctt54', 1)\n",
      "('bms-824171', 1)\n",
      "('1% triton x-100 ] inhibitor nc-2-40', 1)\n",
      "('1% triton x-100 ] inhibitor jrb-4-81', 1)\n",
      "('1% triton x-100 ] inhibitor jrb-4-73', 1)\n",
      "('not epz031686', 1)\n",
      "('1% triton x-100 ] inhibitor mp1c', 1)\n",
      "('1% triton x-100 ] inhibitor mp1d', 1)\n",
      "('hispidulin', 1)\n",
      "('zd7155', 1)\n",
      "('sb-203580', 1)\n",
      "('gsk2850163', 1)\n",
      "('mrl-673', 1)\n",
      "('luteolin', 1)\n",
      "('dexamethasone', 1)\n",
      "(\"7,3',4'-trihydroxyisoflavone\", 1)\n",
      "('mrl-299', 1)\n",
      "('apigenin', 1)\n",
      "('biaryl urea', 1)\n",
      "('1% triton x-100 ] inhibitor t33', 1)\n",
      "('sts', 1)\n",
      "('bestatin', 1)\n",
      "('52% inhibition at 495um', 1)\n",
      "('benzimidazole', 1)\n",
      "('code is 4yu0 in paper', 1)\n",
      "('mrl-871', 1)\n",
      "('space group p 61 2 2', 1)\n",
      "('1% triton x-100 ] inhibitor t33d', 1)\n",
      "('100um nad', 1)\n",
      "('250um gw323434x', 1)\n",
      "('quercetin', 1)\n",
      "('code is 4yu1 in paper', 1)\n",
      "('100um sodium ascorbate', 1)\n",
      "('amino acid id is y30f/y55f/y115f/d38n in paper', 1)\n",
      "('another lower resolution structure is 4ze9', 1)\n",
      "('ul04', 1)\n",
      "('oabp2.1', 1)\n",
      "('oabp2.2', 1)\n",
      "('fragement 114', 1)\n",
      "('dka', 1)\n",
      "('1,6-manifg', 1)\n",
      "('two combined units', 1)\n",
      "('ste', 1)\n",
      "('0.05% tween 20', 1)\n",
      "('ee2', 1)\n",
      "('this pdf is protected', 1)\n",
      "('gemfibrozil', 1)\n",
      "('inhibitor bi 885578', 1)\n",
      "('wehi-842', 1)\n",
      "(\"2',4,4'-trihydroxychalcone\", 1)\n",
      "('epz015666', 1)\n",
      "('fragement 328', 1)\n",
      "('glcnac-6-p (nagr', 1)\n",
      "('data from ref 7', 1)\n",
      "('inhibitor ap5a', 1)\n",
      "('rcsb confused code 3x1k and 3x1m', 1)\n",
      "('3-isopropenyl-tropolone', 1)\n",
      "('camp', 1)\n",
      "('3u3', 1)\n",
      "('0.018% (w/v n-dodecyl-beta-d-maltopyranoside] folic acid', 1)\n",
      "('final deposition', 1)\n",
      "(' olinone', 1)\n",
      "('amppnp', 1)\n",
      "('s-pmpapp', 1)\n",
      "('adenosine', 1)\n",
      "('binds an allosteric site at the interface of the two prmt3 subunits', 1)\n",
      "('i-bet858', 1)\n",
      "('(s,r-24', 1)\n",
      "('flufenamic acid', 1)\n",
      "('fragement 162', 1)\n",
      "('isoleucine', 1)\n",
      "('fragement 117', 1)\n",
      "('named 3r4', 1)\n",
      "('compoud 13', 1)\n",
      "('rs mixture of 45t and 3qe', 1)\n",
      "('c-35', 1)\n",
      "('d-serine', 1)\n",
      "('0.1% chaps (sigma c5070', 1)\n",
      "('methazolamide (mza', 1)\n",
      "('without preincubation', 1)\n",
      "('tiratricol', 1)\n",
      "('comopound 5c', 1)\n",
      "('double bond position is different', 1)\n",
      "('100um zncl2', 1)\n",
      "('2.5 ug acetylated bsa/ml] cbr 9379', 1)\n",
      "('compoudn 17', 1)\n",
      "('pdb code is 5g14 in paper', 1)\n",
      "('but 5li3 in rcsb', 1)\n",
      "('3s-cbtbp', 1)\n",
      "('1s', 1)\n",
      "('3s or 1r', 1)\n",
      "('3r', 1)\n",
      "('ring closed in rcsb pdb', 1)\n",
      "('inhibitor (+-31a', 1)\n",
      "('inhibitor h5', 1)\n",
      "('racemate', 1)\n",
      "('pa-10', 1)\n",
      "('protein is mprmt (21-445 in paper', 1)\n",
      "('the pdb code in paper is 5iol', 1)\n",
      "('not 5i0l', 1)\n",
      "('mixture of 3-(rs', 1)\n",
      "('ligand name is 58p or 6e6', 1)\n",
      "('42nm for 3-(s', 1)\n",
      "('not k38r mutant', 1)\n",
      "('inhibitor (+-31b', 1)\n",
      "('why add a h atom compared to cp1 in code 5fwa', 1)\n",
      "('cfe-5-lic', 1)\n",
      "('spr data available', 1)\n",
      "('krc-2', 1)\n",
      "('sj057', 1)\n",
      "('racemic (dl', 1)\n",
      "('crebbp(1/cpd-a', 1)\n",
      "('flow cytometry results', 1)\n",
      "('pkg1beta', 1)\n",
      "('l-glutamine', 1)\n",
      "('adp', 1)\n",
      "('site 2: 2.3um] mp1p-lbd2-1aa', 1)\n",
      "('site 2: 2.3um] mp1p-lbd2-2aa', 1)\n",
      "('inhibitor pj34', 1)\n",
      "('inhibitor arc-3372', 1)\n",
      "('hsc70/bag1 adenosine', 1)\n",
      "('inhibitor arc-3353', 1)\n",
      "('ip3', 1)\n",
      "('ligans is c-di-gmp', 1)\n",
      "('should has a br- iron in ligand', 1)\n",
      "('pcaf/cpd-e', 1)\n",
      "('galnac', 1)\n",
      "('dttp', 1)\n",
      "('cfe-6-lic', 1)\n",
      "('fimhl f18 .hm', 1)\n",
      "('avidin-haba', 1)\n",
      "('sj295', 1)\n",
      "('delta g=-11.6 kcal/mol', 1)\n",
      "('qa', 1)\n",
      "('delta g=-14.2 kcal/mol', 1)\n",
      "('but 440nm in page 5', 1)\n",
      "('inhibitor p6e', 1)\n",
      "('bps', 1)\n",
      "('tn', 1)\n",
      "('but 7.32um in table 2', 1)\n",
      "('mad author', 1)\n",
      "('allosteric inhibitor shp099', 1)\n",
      "('pcaf/cpd-d', 1)\n",
      "('brd4(1/cpd-a', 1)\n",
      "('pxr-lbd with 9cdhra', 1)\n",
      "('delta g=-11.2 kcal/mol', 1)\n",
      "('chemoproteomic affinities', 1)\n",
      "('compound10b', 1)\n",
      "('pfa-m17', 1)\n",
      "('compound9b', 1)\n",
      "('garftase / agf50', 1)\n",
      "('inhibitor vcc234718', 1)\n",
      "('bllb', 1)\n",
      "('garftase / agf23', 1)\n",
      "('bls', 1)\n",
      "('garftase / agf71', 1)\n",
      "('compoud 9f', 1)\n",
      "('l(+-tartrate as the inhibitor and pnpp as the substrate', 1)\n",
      "('ligand codes are fc4 and 6ke', 1)\n",
      "('entrectinib', 1)\n",
      "('garftase / agf145', 1)\n",
      "('garftase / agf94', 1)\n",
      "('garftase / agf117', 1)\n",
      "('garftase / agf147', 1)\n",
      "('garftase / agf118', 1)\n",
      "('7f', 1)\n",
      "('ccg258748', 1)\n",
      "('c127a', 1)\n",
      "('c233a', 1)\n",
      "('(s*,s**-18e', 1)\n",
      "('cell-free', 1)\n",
      "('x-ray mdm2 18   ?25] mdm2 18-125', 1)\n",
      "('ccg224061', 1)\n",
      "('29', 1)\n",
      "('5 in yellow bound to cdk12', 1)\n",
      "('ccg257284', 1)\n",
      "('raffinose (25', 1)\n",
      "('5 bound to bcl6', 1)\n",
      "('human chymase/o-ethylamidoxime 5b', 1)\n",
      "('na/ose', 1)\n",
      "('24 pim1', 1)\n",
      "('chemical formula is wrong', 1)\n",
      "('23 pim1', 1)\n",
      "('20 bound in the pde2a', 1)\n",
      "('na/zan', 1)\n",
      "('8', 1)\n",
      "('com.11', 1)\n",
      "('compund2/jak3', 1)\n",
      "('4 pim1', 1)\n",
      "('ldn-212854', 1)\n",
      "('11', 1)\n",
      "('eed-ebd-eed709', 1)\n",
      "('table 3', 1)\n",
      "('1', 1)\n",
      "('sba_r01', 1)\n",
      "('duppnp', 1)\n",
      "('db-1-264', 1)\n",
      "('rk-21058', 1)\n",
      "('] nvpro/8b', 1)\n",
      "('bay-707', 1)\n",
      "('3 pim1', 1)\n",
      "('cct6', 1)\n",
      "('rk-21107', 1)\n",
      "('gsk128863', 1)\n",
      "('l-his-bound atp-prt', 1)\n",
      "('38a bound in the pde2a', 1)\n",
      "('vadadustat', 1)\n",
      "('7 in irak4', 1)\n",
      "('refers to aurora-aca alone', 1)\n",
      "('lpc 16:0 as substrate', 1)\n",
      "('ps267', 1)\n",
      "('4 in irak4', 1)\n",
      "('gaa', 1)\n",
      "('pp1:ttn', 1)\n",
      "('gba2', 1)\n",
      "('unreacted', 1)\n",
      "('3g', 1)\n",
      "('a1 bound to trka with the jm region', 1)\n",
      "('melk/5', 1)\n",
      "('upa-quercetin', 1)\n",
      "('bcl6/7', 1)\n",
      "('ecgusr/pnpg', 1)\n",
      "('om', 1)\n",
      "('mgadp.vo4', 1)\n",
      "('n1248a=0.51um', 1)\n",
      "('30', 1)\n",
      "('adipate', 1)\n",
      "('ntrc 0060-0', 1)\n",
      "('frag.1', 1)\n",
      "('6', 1)\n",
      "('pb2long-vx787', 1)\n",
      "('mansifg 2', 1)\n",
      "('ligand id lsd.', 1)\n",
      "('bay 1217389', 1)\n",
      "('ethropropazine/hbche', 1)\n",
      "('masitinib', 1)\n",
      "('2-oxoadipate', 1)\n",
      "('frag.5', 1)\n",
      "('mpi-0479605', 1)\n",
      "('usp7/8', 1)\n",
      "('octopinic acid', 1)\n",
      "('g9a-sam-17', 1)\n",
      "('[multiple sites: site1:10nm', 1)\n",
      "('site2: 1um] doxorubicin', 1)\n",
      "('in the presence of ca2+', 1)\n",
      "('nac', 1)\n",
      "('pdk2 + 5', 1)\n",
      "('ep-1-2', 1)\n",
      "('mps-bay2b', 1)\n",
      "('amide 4 bound to subpocket ii of ethr.', 1)\n",
      "('] tnp-atp-bound ckp2x7', 1)\n",
      "('bcl6/1', 1)\n",
      "(\"ligt/2'-amp\", 1)\n",
      "('tlpc lbd/lactate', 1)\n",
      "('nms-p715', 1)\n",
      "(\"ligt/3'-amp\", 1)\n",
      "('pdk2 + 17', 1)\n",
      "('yfir-gmp', 1)\n",
      "('protein is ca ii', 1)\n",
      "('yfibl43p-yfir-gmp', 1)\n",
      "('mnk2-13', 1)\n",
      "('propidium/hbche', 1)\n",
      "('tc-mps1-12', 1)\n",
      "('tln-5', 1)\n",
      "('bay 1161909', 1)\n",
      "('a/victoria(h3n2 pb2 cap-midlink', 1)\n",
      "('benzo[a]pyrene', 1)\n",
      "('segusr/pnpg', 1)\n",
      "('frag.15', 1)\n",
      "('ptp1b delta7 p185g:tcs401', 1)\n",
      "('pbtd-tsp', 1)\n",
      "('cdk2/icec0942', 1)\n",
      "('1e6', 1)\n",
      "('frag.14', 1)\n",
      "('ptp1b:tcs401', 1)\n",
      "('protein is ca i', 1)\n",
      "('imatinib', 1)\n",
      "('nhe-dnj', 1)\n",
      "('4h10', 1)\n",
      "('tln-6', 1)\n",
      "('ptp1b delta 7:tcs401', 1)\n",
      "('az8838', 1)\n",
      "('sfm1-sam', 1)\n",
      "('sah-bound ynl092w', 1)\n",
      "('ptp1b n193a :tcs401', 1)\n",
      "('ptp1b l192a:tcs401', 1)\n",
      "('apparent dissociation constant  values', 1)\n",
      "('pap', 1)\n",
      "('atpmt2/sah', 1)\n",
      "('succinate', 1)\n",
      "('by mst', 1)\n",
      "('gdpbound mfn1imc(t109a', 1)\n",
      "('ptp1b t178a:tcs401', 1)\n",
      "('(omegazzz-ppc-glcnac', 1)\n",
      "('maltotriose', 1)\n",
      "('gsh-migstu', 1)\n",
      "('tln-1', 1)\n",
      "('frag.3', 1)\n",
      "('site1', 1)\n",
      "('glp-sam-13', 1)\n",
      "('frag.16', 1)\n",
      "('tubulin-1s', 1)\n",
      "('flurescent ligand 1', 1)\n",
      "('ft671', 1)\n",
      "('mz1', 1)\n",
      "('protac', 1)\n",
      "('frag.2', 1)\n",
      "('bcl6/4', 1)\n",
      "('dncs-1 bound to penothiazine fd16', 1)\n",
      "('titrated in presence of mg2+', 1)\n",
      "('gsx-migstu', 1)\n",
      "('dncs-1 bound to penothiazine fd44', 1)\n",
      "('histopine', 1)\n",
      "(\"5'-papa\", 1)\n",
      "('bcl6/5', 1)\n",
      "('frag.10', 1)\n",
      "('105055', 1)\n",
      "('bcl6/6', 1)\n",
      "('gtp-bound mfn1imc(t109a', 1)\n",
      "('aba', 1)\n",
      "('cu2017', 1)\n",
      "('glp-sam-17', 1)\n",
      "('ligand:protein ratio is 0.5', 1)\n",
      "('8f (sri-29928', 1)\n",
      "('7b (sri-29731', 1)\n",
      "('7', 1)\n",
      "('9k (sri-30023', 1)\n",
      "('pex14-5', 1)\n",
      "('mutant/inhibitor 7a (sri-29770', 1)\n",
      "('thiamet-g', 1)\n",
      "('18f/wt ns3 4a', 1)\n",
      "('peptidomimetic 7 trans', 1)\n",
      "('hcaii/compound13', 1)\n",
      "('inhibitor 6e (sri-29685', 1)\n",
      "('n-domain of ace bound to 16', 1)\n",
      "('pex14-3', 1)\n",
      "('t790m', 1)\n",
      "('arabinose', 1)\n",
      "('hcaii/compound3', 1)\n",
      "('thioflavin t/hbche', 1)\n",
      "('inhibitor 3g (grl-5311 with wild-type hiv-1 protease', 1)\n",
      "('e119d mutant/inhibitor 7a (sri-29770', 1)\n",
      "('dnj', 1)\n",
      "('19b/wt ns3 4a', 1)\n",
      "('pugnac-imidazole', 1)\n",
      "('decamethonium/hbche', 1)\n",
      "('hca ii/2', 1)\n",
      "('st3', 1)\n",
      "('gal-nhac-dnj', 1)\n",
      "('peptidomimetic 7 cis', 1)\n",
      "('pex14-2', 1)\n",
      "('bcx4161=0.02um', 1)\n",
      "('structure of ligand in pdb is wrong', 1)\n",
      "('s_zl-n-91', 1)\n",
      "('matx+ pf-8380 (2', 1)\n",
      "('k103n/y181c mutant', 1)\n",
      "('y181i mutant', 1)\n",
      "('k101p mutant', 1)\n",
      "('(r-zl-n-91', 1)\n",
      "('mutant v106a/f227l', 1)\n",
      "('itc kb=4x1000 m-1', 1)\n",
      "('protein is c135s mutant', 1)\n",
      "('c-di-gmp', 1)\n",
      "('neutron diffraction (295k', 1)\n",
      "('receptor plus fab', 1)\n",
      "('t53f', 1)\n",
      "('q74r', 1)\n",
      "('y110a', 1)\n",
      "('i135s', 1)\n",
      "('g162e mutant', 1)\n",
      "('citated data', 1)\n",
      "('protein is tnms2', 1)\n",
      "('conformation a', 1)\n",
      "('conformation b', 1)\n",
      "('receptor alone', 1)\n",
      "('o1 state', 1)\n",
      "('o2 state', 1)\n",
      "('two different forms', 1)\n",
      "('bicyclic form', 1)\n",
      "('t-3220137', 1)\n",
      "('protein is klk6 tm (triple mutation', 1)\n",
      "('atc', 1)\n",
      "('r-k1035', 1)\n",
      "('protein is klk6 wt', 1)\n",
      "('using fitc-trap220 peptide', 1)\n",
      "('az13690257', 1)\n",
      "('nvp-ltm976', 1)\n",
      "('ono-2570366', 1)\n",
      "('the code in literature and pdb are inconsistent(6ico & 6ic0', 1)\n",
      "('protein is klk6 sm (single mutation', 1)\n",
      "('ligand  i s tas-120', 1)\n",
      "('gs-4997', 1)\n",
      "('bd2 domain', 1)\n",
      "('s-k1035', 1)\n",
      "('expression system is different from 6n9h', 1)\n",
      "('azd0364', 1)\n",
      "('e16a(1s,2r', 1)\n",
      "('e25a(1s,2r', 1)\n",
      "('l-methionine', 1)\n",
      "('bosutinib', 1)\n",
      "('two ligands: rosiglitazone and oa', 1)\n",
      "('adp=1.5um', 1)\n",
      "('e25b(1r,2s', 1)\n",
      "('t267k', 1)\n",
      "('n-terminal domain', 1)\n",
      "('jnj4796', 1)\n",
      "('amppnp=2.0um', 1)\n",
      "('r351h', 1)\n",
      "('structure 1', 1)\n",
      "('ias373', 1)\n",
      "('hmbpp-08', 1)\n",
      "('d-methionine', 1)\n",
      "('t267r', 1)\n",
      "('ligand structure is inconsistent with the literature', 1)\n",
      "('abt-263', 1)\n",
      "('inhibitor sgt449', 1)\n",
      "('voxilaprevir', 1)\n",
      "('auy922', 1)\n",
      "('snx-2112', 1)\n",
      "('inhibitor ns1', 1)\n",
      "('grl-14213a', 1)\n",
      "('inhibitor ll319', 1)\n",
      "('inhibitor ll320', 1)\n",
      "('citrate', 1)\n",
      "('cmld013075', 1)\n",
      "('mk-8719', 1)\n",
      "('sb4-205', 1)\n",
      "('sb4-202', 1)\n"
     ]
    }
   ],
   "source": [
    "uf = [(f, unknown_flags[f]) for f in unknown_flags]\n",
    "uf.sort(key=lambda x: x[1], reverse=True)\n",
    "for f in uf:\n",
    "    print(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "defff73e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAjEAAAGxCAYAAACTN+exAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjAsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvlHJYcgAAAAlwSFlzAAAPYQAAD2EBqD+naQAAJH1JREFUeJzt3X9UVHXi//HXyMCIHJgUc0aSFPfQT+wXlomV7qpYadZpS3e1tlorW0sjNcNTn5K2ICh/bJmWnVbc/NXZTp6tzUpqN1ajH0rZpvZjN80gQSppwCRQeH//8Hi/O2AWNMPwhufjnPvH3HnP9T0XjWfvmbnjMsYYAQAAWKZbpCcAAADQFkQMAACwEhEDAACsRMQAAAArETEAAMBKRAwAALASEQMAAKxExAAAACsRMQAAwEpEDIAuYcSIERoxYkSkpwEghIgYAABgJSIGAABYiYgBEHEvvfSSzjrrLHk8HqWkpOiRRx7RvHnz5HK5nDHGGC1ZskRnnXWWYmNj1bNnT1111VXauXNn0LGMMSooKFD//v3VvXt3nXPOOXr55Zfb+ykBaAfuSE8AQNf2+uuv6/LLL9fQoUO1du1aNTY2qqCgQHv37g0aN3XqVBUWFmrGjBnKz8/Xvn37dP/99ysjI0MffPCBfD6fJCknJ0c5OTmaMmWKrrrqKpWVlemmm25SY2OjTj755Eg8RQBh4jLGmEhPAkDXdf7556usrEyfffaZunfvLkmqra3VgAEDtG/fPhlj9Pbbb2vo0KGaP3++Zs6c6Ty2vLxcJ510kqZPn678/Hx9++236tu3ry655BI9//zzzriSkhINGzZMw4cP1xtvvNHeTxFAmPByEoCI+e6777R582ZdeeWVTsBIUnx8vC677DLn9t///ne5XC5dc801OnTokLP5/X6deeaZTpi89dZb+v777zV58uSgPycjI0P9+/dvl+cEoP3wchKAiKmurlZTU5P8fn+L+/533969e2WMcV4yam7gwIGSpG+++abFY492PACdAxEDIGJ69uwpl8ulysrKFvf9777evXvL5XJp48aN8ng8LcYe2ZeYmNjisf97vAEDBoRo5gA6Al5OAhAxcXFxOu+88/T888/r+++/d/bX1tbqxRdfdG6PGzdOxhh9+eWXGjx4cItt0KBBkg6/v6Z79+5atWpV0J9TUlKi3bt3t8+TAtBuWIkBEFF//OMfdfHFF2v06NGaNWuWGhsblZ+fr7i4OO3bt0+SNGzYMN1888264YYbtGXLFl100UWKi4tTRUWFNm3apEGDBukPf/iDevbsqdmzZ+uBBx7QjTfeqKuvvlplZWWaN28eLycBnRCfTgIQcS+++KLuueceffzxx/L7/Zo2bZrq6uqUk5Oj//1P1PLly/Xkk09q27ZtampqUlJSkoYNG6YZM2YoPT1d0uHrxOTn52vJkiXau3evTjnlFD344IN65JFHJIlPJwGdCBEDoEOaN29ei4gBgP/Fe2IAAICViBgAAGAlXk4CAABWYiUGAABYiYgBAABWImIAAICVOu3F7pqamrRnzx7Fx8fL5XJFejoAAOAnMMaotrZWSUlJ6tbt2GstnTZi9uzZo+Tk5EhPAwAAtEFZWZn69et3zDGdNmLi4+MlHT4JCQkJEZ4NAAD4KWpqapScnOz8Hj+WThsxR15CSkhIIGIAALDMT3krCG/sBQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAldytfcC//vUvPfzwwyotLVVFRYXWrVunK664wrnfGKOcnBwtW7ZM1dXVGjJkiB5//HGdfvrpzpj6+nrNnj1ba9asUV1dnUaOHKklS5aoX79+zpjq6mrNmDFDL7zwgiRp/Pjxeuyxx3Tccce1/dkCOKoB2S+F7difPzQ2bMcG0LW1OmK+++47nXnmmbrhhhv061//usX9BQUFWrBggQoLC3XSSSfpgQce0OjRo/XJJ58oPj5ekpSVlaUXX3xRa9euVWJiombNmqVx48aptLRUUVFRkqRJkyapvLxcr7zyiiTp5ptv1rXXXqsXX3zx5zxfAO0sXIFEHAFwGWNMmx/scgWtxBhjlJSUpKysLN11112SDq+6+Hw+5efna+rUqQoEAjr++OP1zDPPaOLEiZKkPXv2KDk5WevXr9eYMWP00Ucf6bTTTtPbb7+tIUOGSJLefvttDR06VB9//LFOPvnkH51bTU2NvF6vAoGAEhIS2voUgS4hnCsx4ULEAJ1Ta35/h/Q9Mbt27VJlZaUyMzOdfR6PR8OHD1dJSYkkqbS0VAcPHgwak5SUpLS0NGfMW2+9Ja/X6wSMJJ1//vnyer3OmObq6+tVU1MTtAEAgM4rpBFTWVkpSfL5fEH7fT6fc19lZaViYmLUs2fPY47p06dPi+P36dPHGdNcXl6evF6vsyUnJ//s5wMAADqusHw6yeVyBd02xrTY11zzMUcbf6zjzJ07V4FAwNnKysraMHMAAGCLkEaM3++XpBarJVVVVc7qjN/vV0NDg6qrq485Zu/evS2O/9VXX7VY5TnC4/EoISEhaAMAAJ1XSCMmJSVFfr9fRUVFzr6GhgYVFxcrIyNDkpSenq7o6OigMRUVFdq2bZszZujQoQoEAnr33XedMe+8844CgYAzBgAAdG2t/oj1/v379d///te5vWvXLm3dulW9evXSiSeeqKysLOXm5io1NVWpqanKzc1Vjx49NGnSJEmS1+vVlClTNGvWLCUmJqpXr16aPXu2Bg0apFGjRkmSTj31VF188cW66aab9OSTT0o6/BHrcePG/aRPJgEAgM6v1RGzZcsW/fKXv3Ruz5w5U5J03XXXqbCwUHPmzFFdXZ2mTZvmXOxuw4YNzjViJGnhwoVyu92aMGGCc7G7wsJC5xoxkrRq1SrNmDHD+RTT+PHjtXjx4jY/UQAA0Ln8rOvEdGRcJwb46bhODICOImLXiQEAAGgvRAwAALASEQMAAKxExAAAACsRMQAAwEpEDAAAsBIRAwAArETEAAAAKxExAADASkQMAACwEhEDAACsRMQAAAArETEAAMBKRAwAALCSO9ITAIC2GJD9UtiO/flDY8N2bAChw0oMAACwEhEDAACsRMQAAAArETEAAMBKRAwAALASEQMAAKzER6wBoJ3wsXAgtFiJAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJX42gHAIuG8bD0A2IaVGAAAYCUiBgAAWImIAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAlrtgLAM1wZWTADqzEAAAAKxExAADASkQMAACwEhEDAACsRMQAAAArETEAAMBKRAwAALASEQMAAKxExAAAACtxxV4gxLjaKwC0D1ZiAACAlYgYAABgJSIGAABYiffEAEAnEK73Yn3+0NiwHBcIBVZiAACAlYgYAABgpZBHzKFDh3TPPfcoJSVFsbGxGjhwoO6//341NTU5Y4wxmjdvnpKSkhQbG6sRI0Zo+/btQcepr6/X9OnT1bt3b8XFxWn8+PEqLy8P9XQBAIClQh4x+fn5euKJJ7R48WJ99NFHKigo0MMPP6zHHnvMGVNQUKAFCxZo8eLF2rx5s/x+v0aPHq3a2lpnTFZWltatW6e1a9dq06ZN2r9/v8aNG6fGxsZQTxkAAFgo5G/sfeutt3T55Zdr7NjDbwYbMGCA1qxZoy1btkg6vAqzaNEi3X333bryyislSStWrJDP59Pq1as1depUBQIBPf3003rmmWc0atQoSdLKlSuVnJys1157TWPGjAn1tAEAgGVCvhJzwQUX6PXXX9enn34qSfrggw+0adMmXXrppZKkXbt2qbKyUpmZmc5jPB6Phg8frpKSEklSaWmpDh48GDQmKSlJaWlpzpjm6uvrVVNTE7QBAIDOK+QrMXfddZcCgYBOOeUURUVFqbGxUQ8++KB++9vfSpIqKyslST6fL+hxPp9Pu3fvdsbExMSoZ8+eLcYceXxzeXl5ysnJCfXTAQAAHVTIV2KeffZZrVy5UqtXr9Z7772nFStW6JFHHtGKFSuCxrlcrqDbxpgW+5o71pi5c+cqEAg4W1lZ2c97IgAAoEML+UrMnXfeqezsbP3mN7+RJA0aNEi7d+9WXl6errvuOvn9fkmHV1v69u3rPK6qqspZnfH7/WpoaFB1dXXQakxVVZUyMjKO+ud6PB55PJ5QPx0AANBBhXwl5sCBA+rWLfiwUVFRzkesU1JS5Pf7VVRU5Nzf0NCg4uJiJ1DS09MVHR0dNKaiokLbtm37wYgBAABdS8hXYi677DI9+OCDOvHEE3X66afr/fff14IFC/T73/9e0uGXkbKyspSbm6vU1FSlpqYqNzdXPXr00KRJkyRJXq9XU6ZM0axZs5SYmKhevXpp9uzZGjRokPNpJQAA0LWFPGIee+wx/d///Z+mTZumqqoqJSUlaerUqbr33nudMXPmzFFdXZ2mTZum6upqDRkyRBs2bFB8fLwzZuHChXK73ZowYYLq6uo0cuRIFRYWKioqKtRTBgAAFnIZY0ykJxEONTU18nq9CgQCSkhIiPR00IWE64v4gEjgCyDR3lrz+5tvsQYA/KBwRjmBhJ+LL4AEAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAldyRngAQCQOyX4r0FAAAPxMrMQAAwEpEDAAAsBIRAwAArETEAAAAKxExAADASkQMAACwEhEDAACsRMQAAAArETEAAMBKRAwAALASXzsAAIiIcH39x+cPjQ3LcdHxsBIDAACsRMQAAAArETEAAMBKRAwAALASEQMAAKxExAAAACsRMQAAwEpEDAAAsBIRAwAArETEAAAAKxExAADASkQMAACwEl8ACQDoVML1xZISXy7Z0bASAwAArETEAAAAKxExAADASkQMAACwEhEDAACsxKeT0KGF81MGAAC7sRIDAACsRMQAAAArETEAAMBKRAwAALASEQMAAKwUloj58ssvdc011ygxMVE9evTQWWedpdLSUud+Y4zmzZunpKQkxcbGasSIEdq+fXvQMerr6zV9+nT17t1bcXFxGj9+vMrLy8MxXQAAYKGQR0x1dbWGDRum6Ohovfzyy9qxY4fmz5+v4447zhlTUFCgBQsWaPHixdq8ebP8fr9Gjx6t2tpaZ0xWVpbWrVuntWvXatOmTdq/f7/GjRunxsbGUE8ZAABYyGWMMaE8YHZ2tt58801t3LjxqPcbY5SUlKSsrCzdddddkg6vuvh8PuXn52vq1KkKBAI6/vjj9cwzz2jixImSpD179ig5OVnr16/XmDFjWhy3vr5e9fX1zu2amholJycrEAgoISEhlE8R7YjrxADoSPgW6/CrqamR1+v9Sb+/Q74S88ILL2jw4MG6+uqr1adPH5199tl66qmnnPt37dqlyspKZWZmOvs8Ho+GDx+ukpISSVJpaakOHjwYNCYpKUlpaWnOmOby8vLk9XqdLTk5OdRPDQAAdCAhj5idO3dq6dKlSk1N1auvvqpbbrlFM2bM0F/+8hdJUmVlpSTJ5/MFPc7n8zn3VVZWKiYmRj179vzBMc3NnTtXgUDA2crKykL91AAAQAcS8q8daGpq0uDBg5WbmytJOvvss7V9+3YtXbpUv/vd75xxLpcr6HHGmBb7mjvWGI/HI4/H8zNnDwAAbBHylZi+ffvqtNNOC9p36qmn6osvvpAk+f1+SWqxolJVVeWszvj9fjU0NKi6uvoHxwAAgK4t5BEzbNgwffLJJ0H7Pv30U/Xv31+SlJKSIr/fr6KiIuf+hoYGFRcXKyMjQ5KUnp6u6OjooDEVFRXatm2bMwYAAHRtIX856Y477lBGRoZyc3M1YcIEvfvuu1q2bJmWLVsm6fDLSFlZWcrNzVVqaqpSU1OVm5urHj16aNKkSZIkr9erKVOmaNasWUpMTFSvXr00e/ZsDRo0SKNGjQr1lAEAgIVCHjHnnnuu1q1bp7lz5+r+++9XSkqKFi1apMmTJztj5syZo7q6Ok2bNk3V1dUaMmSINmzYoPj4eGfMwoUL5Xa7NWHCBNXV1WnkyJEqLCxUVFRUqKcMAAAsFPLrxHQUrfmcOTourhMDoCPhOjHhF9HrxAAAALQHIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICV3JGeAOw3IPulSE8BANAFsRIDAACsRMQAAAArETEAAMBKRAwAALASEQMAAKxExAAAACsRMQAAwEpEDAAAsBIRAwAArETEAAAAKxExAADASkQMAACwEhEDAACsRMQAAAArETEAAMBKRAwAALASEQMAAKxExAAAACsRMQAAwEpEDAAAsBIRAwAArBT2iMnLy5PL5VJWVpazzxijefPmKSkpSbGxsRoxYoS2b98e9Lj6+npNnz5dvXv3VlxcnMaPH6/y8vJwTxcAAFgirBGzefNmLVu2TGeccUbQ/oKCAi1YsECLFy/W5s2b5ff7NXr0aNXW1jpjsrKytG7dOq1du1abNm3S/v37NW7cODU2NoZzygAAwBJhi5j9+/dr8uTJeuqpp9SzZ09nvzFGixYt0t13360rr7xSaWlpWrFihQ4cOKDVq1dLkgKBgJ5++mnNnz9fo0aN0tlnn62VK1fqww8/1GuvvRauKQMAAIuELWJuvfVWjR07VqNGjQrav2vXLlVWViozM9PZ5/F4NHz4cJWUlEiSSktLdfDgwaAxSUlJSktLc8Y0V19fr5qamqANAAB0Xu5wHHTt2rV67733tHnz5hb3VVZWSpJ8Pl/Qfp/Pp927dztjYmJiglZwjow58vjm8vLylJOTE4rpAwAAC4R8JaasrEy33367Vq5cqe7du//gOJfLFXTbGNNiX3PHGjN37lwFAgFnKysra/3kAQCANUIeMaWlpaqqqlJ6errcbrfcbreKi4v16KOPyu12OyswzVdUqqqqnPv8fr8aGhpUXV39g2Oa83g8SkhICNoAAEDnFfKIGTlypD788ENt3brV2QYPHqzJkydr69atGjhwoPx+v4qKipzHNDQ0qLi4WBkZGZKk9PR0RUdHB42pqKjQtm3bnDEAAKBrC/l7YuLj45WWlha0Ly4uTomJic7+rKws5ebmKjU1VampqcrNzVWPHj00adIkSZLX69WUKVM0a9YsJSYmqlevXpo9e7YGDRrU4o3CAACgawrLG3t/zJw5c1RXV6dp06apurpaQ4YM0YYNGxQfH++MWbhwodxutyZMmKC6ujqNHDlShYWFioqKisSUAQBAB+MyxphITyIcampq5PV6FQgEeH9MmA3IfinSUwAA633+0NhIT6FDaM3vb747CQAAWImIAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAld6QngPYzIPulSE8BAICQYSUGAABYiYgBAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFbiI9YAAHQA4boMxucPjQ3LcTsCVmIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAldyRngCCDch+KdJTAADACqzEAAAAKxExAADASkQMAACwEhEDAACsRMQAAAArETEAAMBKRAwAALASEQMAAKxExAAAACuFPGLy8vJ07rnnKj4+Xn369NEVV1yhTz75JGiMMUbz5s1TUlKSYmNjNWLECG3fvj1oTH19vaZPn67evXsrLi5O48ePV3l5eainCwAALBXyiCkuLtatt96qt99+W0VFRTp06JAyMzP13XffOWMKCgq0YMECLV68WJs3b5bf79fo0aNVW1vrjMnKytK6deu0du1abdq0Sfv379e4cePU2NgY6ikDAAALuYwxJpx/wFdffaU+ffqouLhYF110kYwxSkpKUlZWlu666y5Jh1ddfD6f8vPzNXXqVAUCAR1//PF65plnNHHiREnSnj17lJycrPXr12vMmDE/+ufW1NTI6/UqEAgoISEhnE8xpPjuJABAKH3+0NhIT6FVWvP7O+zviQkEApKkXr16SZJ27dqlyspKZWZmOmM8Ho+GDx+ukpISSVJpaakOHjwYNCYpKUlpaWnOmObq6+tVU1MTtAEAgM4rrBFjjNHMmTN1wQUXKC0tTZJUWVkpSfL5fEFjfT6fc19lZaViYmLUs2fPHxzTXF5enrxer7MlJyeH+ukAAIAOJKwRc9ttt+nf//631qxZ0+I+l8sVdNsY02Jfc8caM3fuXAUCAWcrKytr+8QBAECHF7aImT59ul544QX985//VL9+/Zz9fr9fklqsqFRVVTmrM36/Xw0NDaqurv7BMc15PB4lJCQEbQAAoPMKecQYY3Tbbbfp+eef1z/+8Q+lpKQE3Z+SkiK/36+ioiJnX0NDg4qLi5WRkSFJSk9PV3R0dNCYiooKbdu2zRkDAAC6NneoD3jrrbdq9erV+tvf/qb4+HhnxcXr9So2NlYul0tZWVnKzc1VamqqUlNTlZubqx49emjSpEnO2ClTpmjWrFlKTExUr169NHv2bA0aNEijRo0K9ZQBAICFQh4xS5culSSNGDEiaP/y5ct1/fXXS5LmzJmjuro6TZs2TdXV1RoyZIg2bNig+Ph4Z/zChQvldrs1YcIE1dXVaeTIkSosLFRUVFSopwwAACwU9uvERArXiQEAgOvEAAAAdDhEDAAAsBIRAwAArETEAAAAKxExAADASkQMAACwEhEDAACsRMQAAAArETEAAMBKRAwAALASEQMAAKxExAAAACuF/Fusuwq+qBEAgMhiJQYAAFiJlRgAADqxcL5y8PlDY8N27J+ClRgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAViJiAACAlYgYAABgJSIGAABYiYgBAABWImIAAICViBgAAGAlIgYAAFiJiAEAAFYiYgAAgJWIGAAAYCUiBgAAWImIAQAAVurwEbNkyRKlpKSoe/fuSk9P18aNGyM9JQAA0AF06Ih59tlnlZWVpbvvvlvvv/++LrzwQl1yySX64osvIj01AAAQYR06YhYsWKApU6boxhtv1KmnnqpFixYpOTlZS5cujfTUAABAhLkjPYEf0tDQoNLSUmVnZwftz8zMVElJSYvx9fX1qq+vd24HAgFJUk1NTVjm11R/ICzHBQDAFuH4HXvkmMaYHx3bYSPm66+/VmNjo3w+X9B+n8+nysrKFuPz8vKUk5PTYn9ycnLY5ggAQFfmXRS+Y9fW1srr9R5zTIeNmCNcLlfQbWNMi32SNHfuXM2cOdO53dTUpH379ikxMfGo43+qmpoaJScnq6ysTAkJCW0+DtqG8x9ZnP/I42cQWZz/9meMUW1trZKSkn50bIeNmN69eysqKqrFqktVVVWL1RlJ8ng88ng8QfuOO+64kM0nISGBv8ARxPmPLM5/5PEziCzOf/v6sRWYIzrsG3tjYmKUnp6uoqKioP1FRUXKyMiI0KwAAEBH0WFXYiRp5syZuvbaazV48GANHTpUy5Yt0xdffKFbbrkl0lMDAAAR1qEjZuLEifrmm290//33q6KiQmlpaVq/fr369+/fbnPweDy67777WrxUhfbB+Y8szn/k8TOILM5/x+YyP+UzTAAAAB1Mh31PDAAAwLEQMQAAwEpEDAAAsBIRAwAArETEAAAAKxExkpYsWaKUlBR1795d6enp2rhx4zHHFxcXKz09Xd27d9fAgQP1xBNPtNNMO6fWnP/nn39eo0eP1vHHH6+EhAQNHTpUr776ajvOtvNp7d//I95880253W6dddZZ4Z1gF9Dan0F9fb3uvvtu9e/fXx6PR7/4xS/05z//uZ1m2/m09vyvWrVKZ555pnr06KG+ffvqhhtu0DfffNNOs0UQ08WtXbvWREdHm6eeesrs2LHD3H777SYuLs7s3r37qON37txpevToYW6//XazY8cO89RTT5no6Gjz3HPPtfPMO4fWnv/bb7/d5Ofnm3fffdd8+umnZu7cuSY6Otq899577TzzzqG15/+Ib7/91gwcONBkZmaaM888s30m20m15Wcwfvx4M2TIEFNUVGR27dpl3nnnHfPmm2+246w7j9ae/40bN5pu3bqZP/3pT2bnzp1m48aN5vTTTzdXXHFFO88cxhjT5SPmvPPOM7fcckvQvlNOOcVkZ2cfdfycOXPMKaecErRv6tSp5vzzzw/bHDuz1p7/oznttNNMTk5OqKfWJbT1/E+cONHcc8895r777iNifqbW/gxefvll4/V6zTfffNMe0+v0Wnv+H374YTNw4MCgfY8++qjp169f2OaIH9alX05qaGhQaWmpMjMzg/ZnZmaqpKTkqI956623WowfM2aMtmzZooMHD4Ztrp1RW85/c01NTaqtrVWvXr3CMcVOra3nf/ny5frss8903333hXuKnV5bfgYvvPCCBg8erIKCAp1wwgk66aSTNHv2bNXV1bXHlDuVtpz/jIwMlZeXa/369TLGaO/evXruuec0duzY9pgymunQXzsQbl9//bUaGxtbfCu2z+dr8e3ZR1RWVh51/KFDh/T111+rb9++YZtvZ9OW89/c/Pnz9d1332nChAnhmGKn1pbz/5///EfZ2dnauHGj3O4u/Z+PkGjLz2Dnzp3atGmTunfvrnXr1unrr7/WtGnTtG/fPt4X00ptOf8ZGRlatWqVJk6cqO+//16HDh3S+PHj9dhjj7XHlNFMl16JOcLlcgXdNsa02Pdj44+2Hz9Na8//EWvWrNG8efP07LPPqk+fPuGaXqf3U89/Y2OjJk2apJycHJ100kntNb0uoTX/BpqamuRyubRq1Sqdd955uvTSS7VgwQIVFhayGtNGrTn/O3bs0IwZM3TvvfeqtLRUr7zyinbt2sUXE0dIl/5fqd69eysqKqpFcVdVVbUo8yP8fv9Rx7vdbiUmJoZtrp1RW87/Ec8++6ymTJmiv/71rxo1alQ4p9lptfb819bWasuWLXr//fd12223STr8C9UYI7fbrQ0bNuhXv/pVu8y9s2jLv4G+ffvqhBNOkNfrdfadeuqpMsaovLxcqampYZ1zZ9KW85+Xl6dhw4bpzjvvlCSdccYZiouL04UXXqgHHniA1fh21qVXYmJiYpSenq6ioqKg/UVFRcrIyDjqY4YOHdpi/IYNGzR48GBFR0eHba6dUVvOv3R4Beb666/X6tWreR36Z2jt+U9ISNCHH36orVu3Otstt9yik08+WVu3btWQIUPaa+qdRlv+DQwbNkx79uzR/v37nX2ffvqpunXrpn79+oV1vp1NW87/gQMH1K1b8K/OqKgoSf9/VR7tKFLvKO4ojny87umnnzY7duwwWVlZJi4uznz++efGGGOys7PNtdde64w/8hHrO+64w+zYscM8/fTTfMT6Z2jt+V+9erVxu93m8ccfNxUVFc727bffRuopWK215785Pp3087X2Z1BbW2v69etnrrrqKrN9+3ZTXFxsUlNTzY033hipp2C11p7/5cuXG7fbbZYsWWI+++wzs2nTJjN48GBz3nnnReopdGldPmKMMebxxx83/fv3NzExMeacc84xxcXFzn3XXXedGT58eND4N954w5x99tkmJibGDBgwwCxdurSdZ9y5tOb8Dx8+3EhqsV133XXtP/FOorV///8XERMarf0ZfPTRR2bUqFEmNjbW9OvXz8ycOdMcOHCgnWfdebT2/D/66KPmtNNOM7GxsaZv375m8uTJpry8vJ1nDWOMcRnD+hcAALBPl35PDAAAsBcRAwAArETEAAAAKxExAADASkQMAACwEhEDAACsRMQAAAArETEAAMBKRAwAALASEQMAAKxExAAAACv9P/GaQsaJQzoNAAAAAElFTkSuQmCC",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "removed_ids: 7440\n",
      "pdb_ids: 12136\n",
      "kekul_error 0\n",
      "valence_error 3\n",
      "qed_remove 342\n",
      "ha_remove 109\n",
      "rare_elem_remove 185\n"
     ]
    }
   ],
   "source": [
    "# apply ligand filters\n",
    "from rdkit import Chem\n",
    "from rdkit.Chem import Lipinski\n",
    "from rdkit.Chem import QED\n",
    "from rdkit.Chem import AtomKekulizeException, KekulizeException, AtomValenceException\n",
    "from rdkit import RDLogger\n",
    "\n",
    "RDLogger.DisableLog('rdApp.*')  \n",
    "\n",
    "# this works flawlessly with sdf, but crashes on mol2 due to kekule errors\n",
    "# I think I should prefer mol2 due to chirality and stuff\n",
    "# Check if the sdfs actually have aromatic information or if the lack of it is their reason to work that well\n",
    "#   sdfs do not have any aromatic information\n",
    "\n",
    "# based on leak-proof pdbbind we remove all ligands containing rare elements (less than 0.1% of entries have that element or 19 in total)\n",
    "# additionally, B and Fe have been removed since RosettaLigand is not well set up to handle metals\n",
    "non_rare_elements = ['C', 'S', 'O', 'N', 'Cl', 'P', 'F', 'Br', 'I', 'H']\n",
    "\n",
    "remaining_pbd_ids = []\n",
    "qeds = []\n",
    "ha_counts = []\n",
    "\n",
    "kekul_error = 0\n",
    "valence_error = 0\n",
    "qed_remove = 0\n",
    "ha_remove = 0\n",
    "rare_elem_remove = 0\n",
    "\n",
    "for pdb_code in pdb_ids:\n",
    "    #mol_path = 'pdbbind_2020plus/' + pdb_code + '/' + pdb_code + '_ligand.mol2'\n",
    "    #mol = Chem.MolFromMol2File(mol_path, sanitize=True, removeHs=True, cleanupSubstructures=True)\n",
    "    mol_path = 'pdbbind_2020plus/' + pdb_code + '/' + pdb_code + '_ligand.sdf'\n",
    "    mol = Chem.MolFromMolFile(mol_path, sanitize=False, removeHs=False)\n",
    "\n",
    "    removed = False\n",
    "    try:\n",
    "        qed = QED.qed(mol)\n",
    "        qeds.append(qed)\n",
    "    except (AtomKekulizeException, KekulizeException):\n",
    "        #print(pdb_code)\n",
    "        kekul_error += 1\n",
    "        removed_ids.append((pdb_code, 'kekule'))\n",
    "        removed = True\n",
    "    except AtomValenceException:\n",
    "        valence_error += 1\n",
    "        removed_ids.append((pdb_code, 'valence'))\n",
    "        removed = True\n",
    "\n",
    "    if qed <= 0.1:\n",
    "        qed_remove += 1\n",
    "        removed_ids.append((pdb_code, 'qed'))\n",
    "        removed = True\n",
    "\n",
    "    numHeavyAtms = Lipinski.HeavyAtomCount(mol)\n",
    "    ha_counts.append(numHeavyAtms)\n",
    "    if numHeavyAtms < 8 or numHeavyAtms > 500:\n",
    "        ha_remove += 1\n",
    "        removed_ids.append((pdb_code, 'heavy atom count'))\n",
    "        removed = True\n",
    "\n",
    "    for atm in mol.GetAtoms():\n",
    "        if atm.GetSymbol() not in non_rare_elements:\n",
    "            rare_elem_remove += 1\n",
    "            removed_ids.append((pdb_code, 'rare element'))\n",
    "            removed = True\n",
    "\n",
    "    if not removed:\n",
    "        remaining_pbd_ids.append(pdb_code)\n",
    "\n",
    "from matplotlib import pyplot as plt\n",
    "\n",
    "plt.hist(qeds, bins=20)\n",
    "plt.title('qed')\n",
    "plt.show()\n",
    "\n",
    "plt.hist([c for c in ha_counts if c <= 20], bins=20)\n",
    "plt.title('heavy atoms')\n",
    "plt.show()\n",
    "\n",
    "print('removed_ids:', len(removed_ids))\n",
    "print('pdb_ids:', len(remaining_pbd_ids))\n",
    "print('kekul_error', kekul_error)\n",
    "print('valence_error', valence_error)\n",
    "print('qed_remove', qed_remove)\n",
    "print('ha_remove', ha_remove)\n",
    "print('rare_elem_remove', rare_elem_remove)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "ebb575ca",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "15098 of 15098 mols have hydrogens\n",
      "0 sdf have aromatic bonds\n",
      "15098 mols have aromatic bonds after being processed by rdkit\n"
     ]
    }
   ],
   "source": [
    "# check if sd files contain hydrogens and aromatic bonds\n",
    "\n",
    "aromatics = 0\n",
    "aromatic_rdkit = 0\n",
    "hydrogens = 0\n",
    "\n",
    "for pdb_id in remaining_pbd_ids:\n",
    "    sdf_path = 'pdbbind_2020plus/' + pdb_code + '/' + pdb_code + '_ligand.sdf'\n",
    "    has_hydrogen = False\n",
    "    has_aromatic = False\n",
    "    has_aromatic_rdkit = False\n",
    "    mol = Chem.MolFromMolFile(mol_path, sanitize=True, removeHs=True)\n",
    "    try:\n",
    "        aroats = mol.GetAromaticAtoms()\n",
    "        if len(aroats) > 0:\n",
    "            has_aromatic_rdkit = True\n",
    "    except:\n",
    "        print(pdb_id)\n",
    "        break\n",
    "    with open(sdf_path) as file:\n",
    "        for line in file:\n",
    "            if len(line) > 50:\n",
    "                if line[31] == 'H':\n",
    "                    has_hydrogen = True\n",
    "            elif len(line) == 19:\n",
    "                if line[8] == '4':\n",
    "                    has_aromatic = True\n",
    "    if has_hydrogen:\n",
    "        hydrogens += 1\n",
    "    if has_aromatic:\n",
    "        aromatics += 1\n",
    "    if has_aromatic_rdkit:\n",
    "        aromatic_rdkit += 1\n",
    "print(hydrogens, 'of', len(remaining_pbd_ids), 'mols have hydrogens')\n",
    "print(aromatics, 'sdf have aromatic bonds')\n",
    "print(aromatic_rdkit, 'mols have aromatic bonds after being processed by rdkit')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "4708aa79",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|| 12136/12136 [03:23<00:00, 59.63it/s] \n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'CGA': 1, 'LLP': 59, 'FTR': 1, 'ACE': 1, 'MSE': 61, 'PYR': 6, 'CME': 11, 'OCS': 24, 'KCX': 56, 'CSO': 9, 'CSD': 7, 'ALY': 3, 'FME': 2, 'TPO': 6, 'SEP': 7, 'PCA': 1, 'OCY': 4, 'M3L': 3, 'CMH': 1, 'TRQ': 3, 'MDO': 4, 'MHO': 1, 'CSX': 5, 'TPQ': 3, 'SCY': 1, 'CAS': 15, 'SGB': 1, 'CAF': 12, 'SNC': 1, 'MHS': 1, 'AGM': 1, 'GL3': 1, 'KPI': 1, 'MLY': 5, 'SUN': 1, 'PHQ': 1, '4H0': 1, 'FT6': 1, 'LED': 1, 'YOF': 1, 'PTR': 1, 'PHD': 2, '4AK': 1, 'YCM': 1, 'SNN': 1, 'CSS': 2, 'IAS': 1}\n",
      "{' ZN': 1448, 'HOH': 11463, ' IN': 1, ' MG': 583, ' CA': 208, 'PLP': 19, ' MN': 247, ' FE': 59, 'FE2': 23, 'BCB': 3, ' NA': 117, '  K': 67, ' NI': 49, ' CU': 9, ' CD': 9, ' CO': 40, 'HEM': 6, 'NAG': 8, ' SR': 1, ' HG': 3, 'ARS': 5, 'MGF': 1, 'F43': 1, ' CS': 1, 'DOD': 8, 'ALF': 1, 'F3S': 1, 'SF4': 5, 'BMA': 1, 'MAN': 1, ' EU': 1}\n",
      "200\n",
      "54\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "removed_ids: 8034\n",
      "pdb_ids: 11542\n",
      "size_removed 200\n",
      "co_ligand_removed 80\n",
      "mutated_residue_removed 314\n"
     ]
    }
   ],
   "source": [
    "# clean pdb files\n",
    "\n",
    "from scipy.spatial import cKDTree\n",
    "from tqdm import tqdm\n",
    "\n",
    "hetatm_res_close_to_ligand = {}\n",
    "hetatm_lig_close_to_ligand = {}\n",
    "protein_sizes = []\n",
    "\n",
    "# these are metal ions present in the binding pocket which will be kept because they appear at more than 0.1% of all pdbbind structures\n",
    "keep_ligands = [' ZN', ' MG', ' MN', ' CA', ' NA', '  K', ' FE', ' NI', ' CO', 'FE2', 'HOH']\n",
    "# these are modified residues in the binding pocket occuring at more than 0.1% entries. They won't be kept for now because Rosettas clean_pdb transfers them to canonical variants\n",
    "frequent_special_residues = ['MSE', 'LLP', 'KCX', 'OCS', 'CAS']\n",
    "# watery structures are not problematic, but I will remove waters\n",
    "remove_from_file = ['HOH']\n",
    "\n",
    "final_pdbs = []\n",
    "size_removed = 0\n",
    "co_ligand_removed = 0\n",
    "mutated_residue_removed = 0\n",
    "\n",
    "for pdb_id in tqdm(remaining_pbd_ids):\n",
    "    sdf_path = 'pdbbind_2020plus/' + pdb_id + '/' + pdb_id + '_ligand.sdf'\n",
    "    pdb_path = 'pdbbind_2020plus/' + pdb_id + '/' + pdb_id + '_protein.pdb'\n",
    "\n",
    "    # find all chains and hetatms in contact with the ligand\n",
    "\n",
    "    # parse all pdb atoms first to build the tree\n",
    "    atm_pos = []\n",
    "    atm_chain = []\n",
    "    atm_names = []\n",
    "    atm_res = []\n",
    "    atm_nums = []\n",
    "    res_nums = []\n",
    "    counted_terminal_sigs = []\n",
    "\n",
    "    with open(pdb_path) as file:\n",
    "        ter_counter = 0\n",
    "        for line in file:\n",
    "            is_atom = line[0:4] == 'ATOM'\n",
    "            is_hetatm = line[0:6] == 'HETATM'\n",
    "\n",
    "            if line[0:3] == 'TER':\n",
    "                ter_counter += 1\n",
    "\n",
    "            if is_atom or is_hetatm:\n",
    "                chain = line[21]\n",
    "                x = float(line[30:38])\n",
    "                y = float(line[38:46])\n",
    "                z = float(line[46:54])\n",
    "                res_name = 'Protein'\n",
    "                atm_name = 'Protein'\n",
    "                atm_num = int(line[6:11])\n",
    "                res_num = int(line[22:26])\n",
    "\n",
    "            if is_hetatm:\n",
    "                res_name = line[17:20]\n",
    "                atm_name = line[12:16]\n",
    "\n",
    "            if is_atom or is_hetatm:\n",
    "                atm_pos.append([x, y, z])\n",
    "                atm_chain.append(chain)\n",
    "                atm_names.append(atm_name)\n",
    "                atm_res.append(res_name)\n",
    "                atm_nums.append(atm_num)\n",
    "                res_nums.append(res_num)\n",
    "                counted_terminal_sigs.append(ter_counter)\n",
    "\n",
    "    # build tree\n",
    "    tree = cKDTree(atm_pos)\n",
    "\n",
    "    # parse ligand coordinates\n",
    "    all_points = set()\n",
    "    with open(sdf_path) as file:\n",
    "        for line in file:\n",
    "            line_arr = line.strip().split()\n",
    "            if len(line_arr) == 10:\n",
    "                x = float(line_arr[0])\n",
    "                y = float(line_arr[1])\n",
    "                z = float(line_arr[2])\n",
    "\n",
    "                point_idx = tree.query_ball_point([x, y, z], 7.0)\n",
    "                all_points.update(point_idx)\n",
    "\n",
    "    remaining_chains = set()\n",
    "    additional_residues = set()\n",
    "    additional_ligands = set()\n",
    "    non_chain_block_ter_count = max(counted_terminal_sigs)\n",
    "    for idx in all_points:\n",
    "        if atm_names[idx] == 'Protein':\n",
    "            remaining_chains.add(atm_chain[idx])\n",
    "        else:\n",
    "            #print(atm_chain[idx], atm_nums[idx], atm_names[idx], atm_res[idx])\n",
    "            if counted_terminal_sigs[idx] == non_chain_block_ter_count:\n",
    "                additional_ligands.add(atm_res[idx])\n",
    "            else:\n",
    "                additional_residues.add(atm_res[idx])\n",
    "    \n",
    "    # count in how many entries a special residue close the ligand is present\n",
    "    for res in additional_residues:\n",
    "        if res not in hetatm_res_close_to_ligand:\n",
    "            hetatm_res_close_to_ligand[res] = 0\n",
    "        hetatm_res_close_to_ligand[res] += 1\n",
    "\n",
    "    has_co_ligand = False\n",
    "    for res in additional_ligands:\n",
    "        if res not in hetatm_lig_close_to_ligand:\n",
    "            hetatm_lig_close_to_ligand[res] = 0\n",
    "        hetatm_lig_close_to_ligand[res] += 1\n",
    "        if res not in keep_ligands:\n",
    "            has_co_ligand = True\n",
    "\n",
    "    size = 0\n",
    "    for chain in remaining_chains:\n",
    "        remaining_residues = set()\n",
    "        for i in range(len(atm_chain)):\n",
    "            if atm_chain[i] == chain:\n",
    "                remaining_residues.add(res_nums[i])\n",
    "        size += len(remaining_residues)\n",
    "    protein_sizes.append(size)\n",
    "\n",
    "    if size > 1000:\n",
    "        removed_ids.append((pdb_id, 'size'))\n",
    "        size_removed += 1\n",
    "        continue\n",
    "    if has_co_ligand:\n",
    "        removed_ids.append((pdb_id, 'co ligand'))\n",
    "        co_ligand_removed += 1\n",
    "        continue\n",
    "    if len(additional_residues) > 0:\n",
    "        removed_ids.append((pdb_id, 'mutated residue'))\n",
    "        mutated_residue_removed += 1\n",
    "        continue\n",
    "\n",
    "    final_pdbs.append(pdb_id)\n",
    "\n",
    "    # TODO: Write code to write clean pdb files\n",
    "    #       Flag files with water close to ligand\n",
    "\n",
    "print(hetatm_res_close_to_ligand)\n",
    "print(hetatm_lig_close_to_ligand)\n",
    "print(len([s for s in protein_sizes if s > 1000]))\n",
    "print(len([s for s in protein_sizes if s > 1500]))\n",
    "\n",
    "plt.hist(protein_sizes, bins=20)\n",
    "plt.title('num residues')\n",
    "plt.show()\n",
    "\n",
    "print('removed_ids:', len(removed_ids))\n",
    "print('pdb_ids:', len(final_pdbs))\n",
    "print('size_removed', size_removed)\n",
    "print('co_ligand_removed', co_ligand_removed)\n",
    "print('mutated_residue_removed', mutated_residue_removed)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "7377076b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[(61, 'MSE'), (59, 'LLP'), (56, 'KCX'), (24, 'OCS')]\n",
      "[(11463, 'HOH'), (1448, ' ZN'), (583, ' MG'), (247, ' MN'), (208, ' CA'), (117, ' NA'), (67, '  K'), (59, ' FE'), (49, ' NI'), (40, ' CO'), (23, 'FE2')]\n"
     ]
    }
   ],
   "source": [
    "print(sorted([(hetatm_res_close_to_ligand[key], key) for key in hetatm_res_close_to_ligand if hetatm_res_close_to_ligand[key] > 19], reverse=True))\n",
    "print(sorted([(hetatm_lig_close_to_ligand[key], key) for key in hetatm_lig_close_to_ligand if hetatm_lig_close_to_ligand[key] > 19], reverse=True))"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "pdbbind_dock",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
